0/3-hour esc algorithm
1-year mortality
1-year survival
10-year ascvd risk
10-year follow-up
10-year survival
12-lead electrocardiogram (ecg)
18f-fdg pet
2-d echocardiography
2-vessel disease with proximal lad involvement
2-year survival
20-year ascvd risk
22q11 deletion syndrome
22q11.2 deletion syndrome
2mace score
3-d cardiovascular magnetic resonance (cmr) imaging
3-d ct scanning
3-dimensional echocardiography
3-dimensional strain analysis
3-dimensional transesophageal echocardiography (tee)
3-generation family history
3-vessel coronary artery disease
3-year survival free of heart transplant
30-day mortality
30-day readmission
30-year ascvd risk
4-d computed tomography
4-d flow mri
4-factor prothrombin complex concentrate (4-pcc)
4d ct imaging
5 a’s behavior change framework
5-year amputation-free survival
5-year risk estimate
5-year survival
5-year survival after aortic repair
6-minute walk distance (6mwd)
6-minute walk test (6mwt)
99mtc-pyp scintigraphy
99th percentile upper reference limit
a to z trial (aggrastat to zocor study)
a-heft trial (african-american heart failure trial)
a2/p2 mitral valve scallops
aaa growth rate
aaa management strategies
aaa repair
aaa-related mortality
aaa-related rupture
aacvpr (american association of cardiovascular and pulmonary rehabilitation)
aapa (american academy of physician assistants)
aats (american association for thoracic surgery)
abbott (cardiovascular device manufacturer)
abbott laboratories
abbott vascular
abbvie
abc (association of black cardiologists)
abcd trial (appropriate blood pressure control in diabetes)
abciximab
abdominal adiposity
abdominal aortic aneurysm
abdominal aortic aneurysm (aaa)
abdominal aortic aneurysm screening
abdominal aortic ultrasound
abdominal distention
abdominal pain
abi surveillance intervals
abiomed
ablation complications
ablation efficacy
ablation failure
ablation in adult congenital heart disease
ablation outcomes
ablation safety
ablation therapy
ablation vs antiarrhythmic drug therapy for atrial fibrillation
ablation-related adverse events
abnormal ankle–brachial index (abi)
abnormal blood pressure response to exercise
abnormal cardiovascular function
abnormal electrocardiogram
abscess
absolute ascvd risk
absolute risk reduction
academic research consortium high bleeding risk criteria
acc (american college of cardiology)
acc/aha aortic disease guidelines
acc/aha atrial fibrillation guideline
acc/aha clinical practice guidelines
acc/aha coronary revascularization guidelines
acc/aha guideline recommendations
acc/aha heart failure guidelines
acc/aha hypertension guidelines
acc/aha joint guideline committees
acc/aha peripheral artery disease guidelines
acc/aha pooled cohort equations
acc/aha primary prevention guidelines
acc/aha secondary prevention guidelines
acc/aha valvular heart disease guideline
access to cardiovascular care
access to care
accessory atrioventricular pathways
accessory pathway ablation
accf (american college of cardiology foundation)
accp antithrombotic therapy guidelines
accreditation council for graduate medical education (acgme)
ace (angiotensin-converting enzyme)
ace inhibitor intolerance
ace inhibitor therapy for hfref
ace inhibitors
ace inhibitor–induced cough
ace2-mediated viral tropism
acetylcholine coronary function testing
achd cardiologist care
achd clinical classification
achd guideline-directed management
achd mortality risk scores
achd specialist / program / fellowship / management strategies
achd specialty centers
acquired heart disease
acquired von willebrand syndrome
acromegaly-associated heart failure
acromegaly-related cardiomyopathy
acs differential diagnosis
acs guideline / management / toolkit / algorithm
acs management algorithms
acs management guidelines
acta2 mutation–associated aortopathy
actc1 gene
action icu risk score
action trial
activated clotting time
activated partial thromboplastin time
activated prothrombin complex concentrate
active bleeding on anticoagulation
active malignancy
active systemic infection
activin signaling inhibitors
activity monitoring and tracking
acuity trial (acute catheterization and urgent intervention trial)
acute and chronic heart failure diagnosis guidelines
acute and chronic heart failure in congenital heart disease (acc/aha statement)
acute angle of coronary artery takeoff
acute angulation of the left coronary artery
acute aortic disease
acute aortic dissection
acute aortic dissection diagnostic imaging
acute aortic intramural hematoma (imh)
acute aortic pathology
acute aortic regurgitation (ar)
acute aortic rupture
acute aortic syndrome (aas)
acute aortic syndrome classification (irad system)
acute aortic syndrome imaging criteria
acute atrial fibrillation (af)
acute cardiac care
acute cardiovascular events
acute cardioversion
acute chest pain
acute congenital heart disease (achd)
acute coronary event
acute coronary event classification (stemi vs. nstemi/acs)
acute coronary event complications
acute coronary intervention
acute coronary syndrome (acs)
acute coronary syndromes
acute covid-19 cardiovascular syndrome
acute decompensated heart failure (adhf)
acute decompensation of chronic heart failure (hf)
acute heart failure
acute heart failure (hf)
acute hf with preserved vs. reduced ejection fraction
acute hypotension
acute illnesses
acute inflammatory milieu
acute kidney injury (aki)
acute kidney injury as a cardiovascular complication
acute limb ischemia (ali)
acute lower extremity / lower-limb ischemia
acute management of cardiogenic shock
acute medical management of aortic dissection
acute mitral regurgitation (mr)
acute myocardial dysfunction without prior hf
acute myocardial infarction
acute myocardial infarction (mi / ami)
acute myocardial infarction with heart failure
acute myocardial ischemia
acute myocarditis
acute non-ischemic myocardial injury
acute outcomes
acute pancreatitis (risk from hypertriglyceridemia)
acute pericarditis
acute phlebotomy (250–500 ml blood removal)
acute presentation
acute pulmonary edema
acute pulmonary hypertension
acute rate control
acute renal failure
acute respiratory distress syndrome (ards)
acute reversibility studies during cardiac catheterization
acute severe ar surgical emergency
acute severe symptomatic mr
acute stroke
acute type a aortic dissection
acute type b aortic dissection
acute versus chronic ischemia
acute vs chronic valve disease
acute vs delayed inadequate laao occlusion
ad (type a) aortic dissection with distal extent
ada (american diabetes association)
adam trial (aneurysm detection and management)
adamts19 gene mutation
adaptive cardiac resynchronization therapy (adaptive crt)
adaptive servo-ventilation
adaptive trials
added fats
added fats / added sugar / added sugars (risk factor for heart disease)
added sugar
added sugar (risk factor for cardiovascular disease)
added sugars
addiction therapy
additional surgical or device therapy
adjunctive catheter ablation
adjunctive therapy
adjuvant (adjunctive) revascularization procedures
administration route (iv, oral, continuous infusion)
administrative / claims data for cardiovascular research
administrative and accreditation terms
adolescence to young adulthood (13–18 years) chd care
adolescents / young adults
adonis study (american-australian-african trial)
adrenergic agonists
adrenergic receptor stimulation
adrenomedullin
adsorb trial (acute dissection: stent graft or best medical therapy)
adult care hospitals
adult congenital aortic valve interventions
adult congenital cardiac clinic
adult congenital heart association (acha)
adult congenital heart disease (achd)
adult hcm management strategies
adult icd decision-making
adult single ventricle clinic
adult-onset hypertrophic cardiomyopathy
adulthood (18–80+ years) chd care
adults with eisenmenger syndrome clinical characteristics
advance care planning / directives in heart failure
advanced (stage d) heart failure
advanced age (≥75 y)
advanced cardiac imaging
advanced cardiac therapies
advanced care modalities
advanced congenital cardiac therapies
advanced cvd (severe cardiovascular disease)
advanced dementia
advanced echocardiographic imaging
advanced hcm with heart failure
advanced heart failure
advanced heart failure (hf)
advanced heart failure and transplant cardiologist
advanced heart failure position statements (esc, aha)
advanced heart failure therapies
advanced hf therapies (pre-conception, intra-pump, transplant referral)
advanced hf with preserved ejection fraction (hfpef) in hcm
advanced imaging endpoints
advanced imaging for lv strain and strain-rate
advanced imaging markers of disease progression
advanced kidney disease (non-dialysis / in cad context)
advanced lipid disorders program
advanced liver fibrosis
advanced nyha class (iii or iv)
advanced practice provider(s) (nurse practitioners, physician assistants)
advanced reperfusion strategies (e.g., arrest trial, cares registry)
advanced screening strategies for hf (cost-effectiveness, risk prediction)
advanced therapies (surgical, mechanical support, transplant, mechanical circulatory support, lvoto relief)
advanced treatments (lvad, heart transplant)
advancing age
adventitia
adventitial inflammation
adverse aortic events
adverse cardiac events
adverse cardiovascular events (hospitalization, mortality)
adverse cardiovascular outcomes (stroke, bleeding, mortality)
adverse drug effects
adverse event risk (mortality, hf, stroke, arrhythmia)
adverse events (e.g., tendon rupture, uric acid increase, af)
adverse maternal and fetal outcomes
adverse outcomes (stroke, thromboembolism)
advised risk score
advocacy priorities
aerobic exercise
aerobic exercise (moderate / vigorous intensity)
aerobic exercise safety
aerobic interval training
aerobic training
af (atrial fibrillation)
af ablation / on uninterrupted oral anticoagulation
af and stroke risk / mortality / quality of life / ventricular fibrosis / weight management
af as comorbidity in hf
af burden / metrics / monitoring / duration / episode duration (>24 h or >5 min)
af burden / recurrence / progression / early-onset, “lone” af
af catheter ablation / af ablation
af classification / clinical outcomes / economic evaluation / follow-up investigation (affirm)
af detection from atrial lead
af diagnostic accuracy
af duration thresholds
af episode / frequency / duration
af in adult congenital heart disease / pediatric and young adult populations
af in valvular heart disease (vhd) / non-valvular / obesity / post-operative / subclinical / device-detected / silent
af incidence in cancer subtypes
af initiation triggers
af management / guidelines
af management / guidelines (aha/acc/hrs) / strategies / therapy outcomes / prevention
af prognosis in obesity
af progression / prevention
af recurrence / post-ablation / post-treatment
af recurrence predictors / prediction
af risk
af surveillance
af symptoms
af-chf study / trial
af-mediated / af-induced cardiomyopathy
af-related morbidity
af-related mortality
af-related stroke risk / thromboembolic risk
affirm study / affirm trial (substudy)
affirm-ahf trial
aficamten clinical trials
afl (atrial flutter)
aftr trial (ablate and pace trial)
age (general / advanced / ≥60 y / ≥65 y / ≥70 y / ≥75 y / >80 y)
age at aortic event / age at repair (<6.5 y)
age of af onset (<45 y, <66 y)
age stratification in valve choice (<50, 50–65, >65 y)
age threshold (≥75 y)
age- and lesion-related comorbidity burden in chd
age- and sex-based st-elevation thresholds
age-adjusted hf mortality
age-appropriate risk factors
age-based recommendations (≤65, 65–80, >80 y)
age-dependent valve choice (≤50, 50–65, >65 y)
age-related longevity and valve selection
age-related risk categories (≥85, 75–84, 65–74, <65 y)
age-related susceptibility to af
age-specific risk assessment (20–39, 40–59, 60–75, >75 y)
age-specific risk prediction models
age-standardized global prevalence rates of af / afl
aggressive aortopathy
aggressive blood-pressure control
aggressive cardiovascular phenotype of aneurysms-osteoarthritis syndrome
aggressive decongestion
aggressive diuresis leading to lvoto amplification
agranulocytosis
ahre (atrial high-rate episodes)
ai and machine learning in cardiology
ai for atrial fibrillation management
ai risk prediction
ai-based perfusion mapping
ai-guided atrial fibrillation screening
ai-powered imaging analysis for early pad detection
aim‑high trial
air embolism (intraoperative)
air pollution / ambient air pollution / ambient particulate matter exposure / ambient temperature exposure – cardiovascular risk factors
air versus oxygen therapy in stemi
airway compression symptoms (stridor, wheezing)
ai–ecg (ai-ecg)
aki after coronary procedures
akinetic rvot length ≥55 mm
al amyloidosis
alagille syndrome (jag1) – peripheral/branch pa stenosis, coarctation, aortic stenosis, septal defects, mid-aortic narrowing
albiglutide
albumin / albuminuria (≥30 µg albumin/mg creatinine) – renal function as cvd predictor
alcohol (risk factor for cvd / tobacco-related risk factor)
alcohol abuse / alcoholic cardiomyopathy
alcohol consumption
alcohol consumption / use / moderation / abstinence / reduction (light, moderate, binge, ≤1 drink/day women, ≤2 drinks/day men)
alcohol misuse
alcohol septal ablation (asa) / outcomes
alcohol-induced cardiac toxicity
alcohol-related af episodes
aldactone (spironolactone)
aldosterone antagonist therapy / blockade / pathway blockade / mineralocorticoid receptor blockade
aldosterone antagonists (e.g., spironolactone, eplerenone)
alirocumab (pcsk9 monoclonal antibody)
all-cause mortality
all-in cluster randomized trial (integrated af management)
allogeneic hematopoietic cell transplantation
allograft / allograft cryopreservation / tissue exposure / cryopreserved aorta
alogliptin
alteplase (tpa)
ambrisentan (endothelin receptor antagonist / therapy)
amica trial (atrial fibrillation management in congestive heart failure with ablation)
amino-terminal pro-bnp (nt-probnp)
amiodarone (antiarrhythmic drug / therapy / rate- or rhythm-control / iv / preoperative prophylaxis)
amiodarone-associated thyroid dysfunction (hyperthyroidism, hypothyroidism, thyrotoxicosis)
amlodipine
amyloid cardiomyopathy (al-cm)
amyloid heart disease
amyloidosis (cardiac / infiltrative cardiomyopathy / involvement)
anaphylactic reactions to beta-blockers
anatomic assessment of disease severity
anatomic characteristics / complexity / lesions / variants / variability / etiology / pattern / or ischemic testing
anatomical evaluation of disease / repairs / physiologic classification system
ancillary imaging in achd (e.g., ct-ffr)
anderson-fabry disease (in hypertrophic cardiomyopathy)
andexanet alfa (anti-xa antidote / factor xa inhibitor reversal agent)
andromeda trial (anti-arrhythmic trial with dronedarone)
anemia
anemia (cardiovascular impact / in acs / in heart failure / management with folic acid, iron, transfusions)
anesthesia (epidural / general / local vs. general in aortic surgery)
anesthesia collaboration / management in achd
anesthesia-related cardiac risk (e.g., qtc prolongation)
anesthesiologist with chd expertise
anesthetic planning / pharmacology / management for cardiac surgery / pregnancy
aneurysm (aortic / lv apical / related to dissection / cause)
aneurysm growth / rate / dilation (≥0.5 cm/yr, >0.5 cm in 6 months)
aneurysm neck diameter / sac / sac enlargement / thrombosis prevention
aneurysm repair / aneurysmectomy / surgical aneurysmectomy
aneurysm rupture
aneurysm screening / surveillance / size thresholds (≥5.5 cm men, ≥5.0 cm women, ≥6.0 cm)
aneurysm-related mortality / reintervention / events / death
aneurysmal aorta / segment / area / degeneration / disease / extension (proximal arch, ascending, descending thoracic aorta)
aneurysmal pulmonary arteries / sac / segment replacement
aneurysmal threshold (≥1.5× reference diameter)
aneurysms-osteoarthritis syndrome
angina
angina / angina pectoris / chest pain / anginal pain
angina frequency / baseline angina frequency
angina ongoing / angina under-recognition
angina pectoris
angina prevalence (including provider evaluation study)
angina quality of life / angina-related qol
angina symptoms / anginal symptoms (dyspnea, arm pain with exertion)
angina types: stable angina / unstable angina / refractory angina
anginal episodes / anginal symptom burden
angiogenesis
angiogram / angiography (coronary / contrast-enhanced / invasive / vascular imaging)
angiographic assessment (stenosis ≥50 %, complexity, chronic coronary disease, progression, patterns, hemodynamic significance)
angiography grade (1–4)
angiography-guided pci / angiography-guided strategy
angiology (clinical specialty)
angioplasty / percutaneous coronary angioplasty / angioplasty-first vs. bypass-first strategy
angiosafe / angiosome / angiosome-targeted revascularization / direct pulsatile flow
angiosomal revascularization strategies
angiotensin ii receptor blockade / antagonists
angiotensin ii receptor blockers (arb / arbs / examples: losartan, valsartan, candesartan)
angiotensin receptor blockers / therapy for hfref / general use
angiotensin receptor–neprilysin inhibitors (arni / sacubitril-valsartan) / therapy in hfref or achd / pre-hf stage b
angiotensin-converting enzyme inhibition
angiotensin-converting enzyme inhibitors (acei / ace-i / examples: enalapril, ramipril, captopril, fosinopril, lisinopril, perindopril, quinapril, trandolapril)
angiotensin-ii-dependent tgf-β signaling
angiotensin-neprilysin inhibition / antagonist
ankle pulse volume recordings (pvr)
ankle-brachial index (abi) / measurement / interpretation / diagnostic thresholds (<0.80, ≤0.90, <0.9)
ankle–brachial index (abi)
annular abscess / dilation / hypoplasia
annular-to-coronary ostial distance (ct measurement for tavi planning)
annuloplasty / annuloplasty repair / ring(s)
annulus area / size / shape / washer technique / rupture
anomalous aortic origin of coronary artery (aaoca) / from opposite sinus
anomalous left coronary artery (alca / alcapa) / from pulmonary artery
anomalous origin of coronary arteries / opposite sinus of valsalva
anomalous papillary muscle / insertion
anomalous pulmonary venous connection / return (partial or total) / apvc
anomalous right coronary artery (arca / arcapa) / from pulmonary artery / left sinus of valsalva
antegrade cerebral perfusion / antegrade perfusion
antegrade propagation / antegrade propagation of dissection
antegrade stenting of descending thoracic aorta / proximal descending thoracic aorta
anterior aortoiliac disease
anterior free wall
anterior mitral leaflet extension
anterior stemi / antero-apical infarction
anterior-lateral thoracotomy
anterior-posterior (annular) dilation
anthracycline cardiotoxicity / induced cardiomyopathy / anthracycline-related cardiotoxicity
anthracyclines (doxorubicin, epirubicin, idarubicin, mitoxantrone)
anthracyclines (from previous list, if including anticancer drugs)
anti-anginal drugs / therapy (e.g., β-blockers, nitrates, ranolazine, nifedipine)
anti-arrhythmic agents / drugs / medication / therapy / follow-up / risk/benefit analysis
anti-arrhythmic drug examples → amiodarone, dofetilide, digoxin
anti-arrhythmic drug therapy (aad) / therapy for rhythm control
anti-arrhythmic effects
anti-cyclic citrullinated peptide (anti-ccp)
anti-double-stranded dna (anti-dsdna)
anti-her2 agents
anti-human leukocyte antigen (anti-hla) antibodies
anti-hypertensive drug examples (beta-blockers, calcium-channel blockers, diuretics)
anti-impulse therapy (beta-blockade, antihypertensive therapy)
anti-inflammatory therapy / diet
anti-ischemic effects
anti-rna polymerase iii
anti-scl-70
anti-ssa (ro) / anti-ssb (la)
anti-tachycardia pacing (atp) / atp algorithms
anti-xa activity / anti-xa agents / direct oral anticoagulants / monitoring / levels
antianginal medications
antiarrhythmic agents / drugs / therapy / follow-up / dosing / maintenance of sinus rhythm (examples: amiodarone, metoprolol)
antiarrhythmic drug therapy (aad) / medical therapy / therapy in ckd
antibiotic therapy / prophylaxis / duration / sensitivity data
antibiotics for lyme carditis
anticoagulant dosing / adjustment / interruption / resumption / titration / drug absorption
anticoagulant therapy / anticoagulation (oral, oacs, doacs, vkas, warfarin)
anticoagulation / anti-coagulation therapy
anticoagulation and antiplatelet therapy
anticoagulation bridging / strategies / safety profile / target inr (2–3)
anticoagulation during pregnancy (including mechanical valves / trimesters)
anticoagulation in amyloidosis / vte prophylaxis / cancer
anticoagulation in atrial fibrillation (valvular / non-valvular / stroke prevention)
anticoagulation in coronary disease
anticoagulation monitoring (inr / last dose / accessibility)
anticoagulation reversal agents / effectiveness / bleeding risk / risk-benefit assessment
anticoagulation strategies
anticoagulation-naïve patients / therapy guidance / strategy independent of cha₂ds₂‑vasc
anticoagulation-related intracerebral hemorrhage / surveillance / anticoagulation-sparing strategies
antidepressant effects
antidepressants (e.g., escitalopram)
antiepileptic drugs
antifungal therapy
antigen-presenting cells (apcs)
antihypertensive agents / drugs / medication / therapy / treatment
antihypertensive medication burden (≥2 drugs / ≥3 classes)
antihypertensive therapy for aortic injury
antimetabolites (clofarabine, cytarabine, 5-fluorouracil, capecitabine, gemcitabine)
antimicrobial agents / therapy / regimens / duration
antimicrobial stewardship / stewardship for prosthetic vascular infections
antimicrobial therapy duration (48 hrs – 1 week / prolonged iv antibiotics)
antimicrobial therapy examples (e.g., cloxacillin, gentamicin)
antimicrobial therapy for aortic infections / foot infections
antimicrotubule agents
antineoplastic drug interactions
antineutrophil cytoplasmic antibody (anca) / anca-related vasculitis / anca-related disease
antinuclear antibody (ana)
antioxidant therapy (vitamin c, beta-carotene, multivitamins)
antioxidants (ascorbic acid, polyunsaturated fatty acids [pufa] for af risk in hf)
antiphospholipid antibody syndrome / antiphospholipid syndrome
antiplatelet agents / drugs / therapy / regimen / response / efficacy / strategy / guidelines
antiplatelet and anticoagulant therapy
antiplatelet therapy
antiplatelet therapy (apt / dual therapy / aspirin / clopidogrel / dapt)
antiplatelet therapy strategies
antithrombin / antithrombin agents
antithrombotic agents / drugs / therapy / regimens / strategies / prophylaxis / safety / efficacy
antithyroid treatment
anxiety / anxiety in achd / anxiety in perioperative aaa patients
aorta
aortic afterload
aortic aneurysm
aortic aneurysm (general, aa, aaa, ascending, thoracic, abdominal, saccular, pseudoaneurysm, infra-inguinal/popliteal)
aortic aneurysm growth / growth rate / sac diameter / surveillance / rupture risk / rupture / diameter thresholds
aortic arch / arch anatomy / arch zones (0–5)
aortic arch aneurysm
aortic ascending aorta
aortic atheroma / atherosclerosis / plaques / calcification / sclerosis
aortic balloon valvuloplasty
aortic bifurcation
aortic biomechanics / geometry / contour defects / knob disruption
aortic branches / branch vessels / branch vessel involvement / arch branch vessels
aortic coarctation (native, repaired)
aortic complications / adverse events / mortality / outcomes
aortic cross-clamping / cross-sectional area / cross-section-to-height ratio
aortic diameter
aortic diameter thresholds for intervention
aortic dilation / dilatation / root dilation / aortopathy / enlargement
aortic disease (clinical statements, guidelines, tad, natural history, epidemiology, pregnancy-specific risk)
aortic disease complications
aortic disease management in pregnancy
aortic dissection
aortic dissection (general, type a, type b, acute, chronic, distal to graft, tad, debakey classifications)
aortic dissection at small diameter
aortic dissection flap
aortic dissection risk / risk assessment / thresholds / detection scores (add-rs)
aortic ectasia / elongation / expansion
aortic events (dissection, rupture, aneurysm growth, surgery)
aortic gradient
aortic imaging (ct angiography, mri, fdg-pet, echocardiography, tee)
aortic imaging techniques / standards / surveillance schedule / monitoring frequency
aortic injury (blunt traumatic, classification schemes, management)
aortic intimal flap
aortic intramural hematoma
aortic involvement in systemic conditions (connective-tissue disorders, familial hypercholesterolemia, turner’s syndrome)
aortic isthmus / isthmus ratio / stenosis / rupture
aortic lumen / orifice
aortic measurement standards / diameter measurement / size / indexing / size index (asi / ahi) / diameter-height ratio
aortic pressure / diastolic pressure equilibration
aortic pseudoaneurysm / anastomotic pseudoaneurysm
aortic pseudoaneurysm / sac thrombosis
aortic pulmonary collaterals / transposition
aortic registry / quality initiative data
aortic regurgitation
aortic repair / reconstruction / replacement / resection / grafting / endovascular repair / endografting
aortic repair types: open surgery, endovascular repair, prophylactic, urgent
aortic replacement / replacement indications / surgical criteria / timing / techniques
aortic root / sinus segment / root anatomy / root dimensions / root area / cross-sectional area / indexed area / aortic area-height ratio
aortic root aneurysm
aortic root repair / remodeling / reconstruction / valve-sparing procedures (david procedure, reimplantation)
aortic rupture
aortic rupture / rupture risk / incidence / free vs. contained
aortic sarcoma / tumor
aortic size thresholds / growth thresholds
aortic stenosis
aortic stiffness / stiffness index
aortic stump oversewing
aortic surgical zones / landing zone definitions (0–4)
aortic surveillance / monitoring / post-repair follow-up / imaging intervals
aortic thrombus / mural thrombosis / thromboembolism
aortic translocation
aortic valve (av) anatomy / leaflets / cusp prolapse / adhesion / tethering
aortic valve disease
aortic valve disease (stenosis, insufficiency/regurgitation, calcification, congenital)
aortic valve hemodynamics (flow velocity, gradient, vmax)
aortic valve intervention / replacement / repair / prosthetic choice (mechanical, bioprosthetic)
aortic valve pathology / molecular genetics / complications / endocarditis
aortic valve surgery / repair / replacement / valve-sparing operations / savr / avr
aortic valve surgical planning / indications / timing / durability / reoperation
aortic velocity / vmax / transvalvular gradient
aortic volume
aortic wall / medial layer / wall abnormalities / wall integrity / wall remodeling / wall biomechanics / wall stress / wall thickening / wall false lumen
aortitis
aortitis / aortic inflammation / involvement in giant cell arteritis / takayasu arteritis
aortobifemoral bypass
aortocaval fistula / aortocavitary fistula
aortoenteric fistula / aorto‑enteric fistula
aortoiliac arterial segment / aortoiliac-femoral occlusive disease
aortoiliac disease / occlusive disease / lesions / pad involvement / femoropopliteal / infrapopliteal segments
aortopathy
aortopathy (general) / aortopathic conditions / associated with bicuspid aortic valve / ≥5 cm diameter / connective-tissue disorders
aortopathy management during pregnancy
aortopulmonary collaterals / aortopulmonary arteriovenous shunt / fistula / shunt closure
aorto‑aortic tube grafting
aorto‑iliac arterial intervention / appropriate use
ap (accessory pathway) / ap classification (ia, ic–d, etc.)
apical hypertrophy / apical hypertrophic cardiomyopathy / apical aneurysm / apical outpouching / apical myectomy / apex-ami trial / apical site pacing / apical sparing of lv longitudinal strain / apically displaced papillary muscles / apical point of maximal impulse
apixaban (artesia trial)
apixaban / artesia trial
appropriate use criteria (auc) for cardiac imaging / echocardiography / vascular diagnostics / multimodality imaging / congenital heart disease
apt – antiplatelet therapy
arb – angiotensin receptor blocker (losartan, valsartan)
arb – angiotensin receptor blocker / agents / class (losartan, valsartan)
arc-hf trial (ablation vs. rate control in persistent af + hf)
area under the curve (auc, pharmacology / clinical scoring)
aric study / aric risk score (atherosclerosis risk in communities)
aric study / aric risk score / atherosclerosis risk in communities
aristotle trial (apixaban efficacy)
arni – angiotensin receptor–neprilysin inhibitor
arrest trial
arrhythmia (general) / atrial / ventricular / tachyarrhythmias / bradyarrhythmias / post-operative / post-cardioversion
arrhythmia / heart rhythm disorder
arrhythmia burden / detection / monitoring / progression / recurrence / substrate identification / management / treatment / strategies
arrhythmia surgery (maze procedures)
arrhythmia-induced cardiomyopathy
arrhythmias during exercise testing / during pregnancy / post-fontan / in adults after rastelli surgery
arrhythmic events / life-threatening arrhythmias / arrhythmic death / arrhythmic phenotypes / arrhythmic risk / risk scores / risk stratification
arrhythmogenic cardiomyopathy (acm) / arrhythmogenic right ventricular cardiomyopathy (arvc) / arrhythmogenic right ventricular dysplasia/cardiomyopathy (arvd/c) / arrhythmogenic substrate
arrhythmogenic right ventricular cardiomyopathy
arterial aneurysm
arterial embolism / thromboembolism / thrombosis / occlusion
arterial intermittent pneumatic compression devices
arterial lactate (≥2.5 mmol/l)
arterial line / vascular access
arterial load / stiffness / tortuosity
arterial phase imaging
arterial revascularization / stenosis
arterial switch operation (d-tga / jatene procedure)
arteriopathy clinic / arteriovenous malformations / arteriovenous fistula-related hf
artificial intelligence (ai)
as – aortic stenosis / asymptomatic as / severe as
asap study / asap-too trial
ascending aorta
ascending aorta aneurysm / thoracic aneurysm (taa) / aaa
ascending aorta dilation / dimensions
ascending aorta procedures / repair / replacement / root replacement surgery
ascending aortic aneurysm
ascending aortic aneurysm outcomes / surgery
ascending aortic calcification (porcelain aorta)
ascending aortic cannulation / complications
ascending aortic dilation
ascending thoracic aorta / thoracic aortic graft
ascvd event risk / events / risk / risk calculator / high-risk clinical factors / prediction models / estimate / risk factors
ascvd – atherosclerotic cardiovascular disease
asd – atrial septal defect / closure
aspirin (acetylsalicylic acid, asa)
aspirin (antiplatelet therapy / monotherapy / for primary prevention / low-dose 75–100 mg, 81 mg daily)
aspirin dosing: low-dose (81 mg) vs high-dose (162–325 mg) / maintenance dose (75–100 mg/day) / loading dose (162–325 mg)
aspirin for asymptomatic atherosclerosis (aaa trial)
aspirin hypersensitivity / desensitization / contraindications / induced hemorrhage / discontinuation strategy
aspirin therapy for pericarditis
aspirin use (cardiovascular prevention, pre-hospital, transplant patients)
assent-3 trial
assessment of cardiovascular risk / chest pain for cad / ischemic myocardium in af patients
asymptomatic adult cardiac risk assessment
asymptomatic aortic regurgitation / severe ar / ar with normal lv function
at – atrial tachycardia
atenolol
atherogenic lipoproteins
atheroma / atherosclerosis / vascular calcification (in ckd) / peripheral arteries / lower extremities
atherosclerosis
atherosclerotic cardiovascular disease
atherosclerotic disease / cardiovascular disease / heart disease / occlusive disease / risk / pathways / plaque / burden / instability / volume
atherosclerotic taa / atherosclerotic vascular disease / atherothrombosis / atherothrombotic events
athlete / athlete population / competitive athletes / athlete’s heart / differential diagnosis / activity restrictions
atlas study (lisinopril low vs high dose)
atorvastatin (10–80 mg, ≥40 mg)
atorvastatin and other statin analogues were covered in previous batches
atria risk score
atria stroke-risk score
atrial annular dilation
atrial arrhythmia (general, including flutter / post-closure / recurrent)
atrial arrhythmia burden / recurrence / detection / suppression (drug trials)
atrial cardiomyopathy / contraction / dysfunction / ectopic beats / electromechanical delay / electrophysiology / electrophysiology abnormalities / enlargement / fatty infiltration
atrial fenestration
atrial fibrillation
atrial fibrillation (af) / afib
atrial fibrillation conversion to sinus rhythm
atrial fibrillation in critical illness
atrial fibrillation–associated thromboembolism
atrial flutter
atrial flutter (afl) / typical & atypical / atypical non-cavotricuspid macroreentrant
atrial flutter (clockwise)
atrial flutter (typical and atypical)
atrial functional mitral regurgitation
atrial high-rate episode (ahre / device-detected)
atrial overdrive pacing / atrial pacing / algorithms / lead / pacemaker lead
atrial septal defect
atrial septal defect (asd) / asd closure / asd / patent foramen ovale (pfo) / atrial septal dilation / atrial septal defects
atrial size / dilation / structural abnormalities / stunning
atrial switch (senning/mustard procedures / surgically induced / operation / repair)
atrial tachyarrhythmia–related av arrhythmias (refractory)
atrial tachycardia (at) / atrial tachyarrhythmias / atypical atrial arrhythmias
atrial tissue / myocyte hypertrophy / interstitial collagen / fibrosis / scarring / substrate
atriclip device / atricure
atrio-ventricular junction ablation / av junctional radiofrequency ablation
atrioesophageal fistula
atriopulmonary fontan / atriotomy scars
attest trial
attr-cm (transthyretin amyloid cardiomyopathy) / attr-v (variant) / attr-wt (wild-type)
augustus trial (antithrombotic therapy after acs/pci in af)
autogenous vein / autogenous vein graft / bypass / conduit / surgery / femoral vein autograft
autograft aortic root replacement
autologous vein graft
automated algorithm detection of af / automated algorithms for af detection
autonomic disorders / dysfunction in amyloidosis / hyperinnervation
autonomic nervous system (ans) / dysfunction / dysregulation / modulation / nerve sprouting / denervation / neuropathy
autosomal dominant inheritance / transmission of taa
av block / av nodal block / high-grade av block
av junction ablation / av nodal ablation / av nodal blockers / av nodal blocking agents / av nodal ablation strategies
av node / displacement / ablation (avna)
av septal defect (avsd) – partial / complete
av synchrony / av dyssynchrony / av conduction / av conduction abnormalities / av conduction block
av valve dysfunction / failure / function / regurgitation / replacement / surgery (systemic av valve repair)
avid trial (antiarrhythmics versus implantable defibrillators)
avoid trial (air versus oxygen in stemi)
avr – aortic valve replacement
axillary / axillofemoral bypass / cannulation
azathioprine (dmard)
azygous vein / azygous continuation of inferior vena cava
b braun medical
b vitamins and omega‑3 fatty acids (cardiovascular effects)
b-natriuretic peptide (bnp)
b-type natriuretic peptide (bnp / nt-probnp)
b-type natriuretic peptide (bnp) / bnp testing / natriuretic peptides
b-type natriuretic peptide ≥127 ng/l
back pain
bacteremia
bacterial aortitis
bacterial endocarditis
bacterial sepsis (cardiovascular impact)
baffle leak / obstruction / stenosis / closure / intervention (e.g., intratrial)
ball-in-cage valve
balloon angioplasty / dilatation / valvuloplasty / occlusion / test occlusion
balloon aortic valvuloplasty (bav) / balloon dilation of the aortic valve
balloon catheter
balloon mitral commissurotomy / valvotomy / valvuloplasty (bmv)
balloon occlusion of the aorta / balloon test occlusion
balloon-expandable percutaneous valves / prostheses / pulmonary valve / valve (e.g., sapien 3)
balloon-expandable prostheses / valves
balloon-expanded stent
bare metal stent (bms) / bare-metal femoropopliteal stent / stents
bari 2d trial results
bariatric procedures / surgery (gastric bypass, sleeve gastrectomy, adjustable gastric banding)
barlow’s valve
barriers to care (geographic, insurance, socioeconomic)
barriers to physical activity in hcm patients
basal anterior septum / basal septal hypertrophy
baseline aortic imaging / coronary imaging / mri/ct / tee / tte
basil-2 trial (bypass vs angioplasty for severe leg ischemia)
basket trials (device / procedural studies)
bbmeta-hf (beta-blockers meta-analysis)
bcl2-like protein 12 (bcl2l12)
beautiful trial (ivabradine in cad with lv dysfunction)
behavior modification / therapy / behavioral coaching / counseling / change techniques
behavioral interventions for tobacco cessation / support
behçet disease / behçet’s disease
bempedoic acid / atp citrate lyase inhibitor / bempedoic acid + ezetimibe combination therapy
benchmarking across centers / performance measures
bendopnea
benefit assessment / benefit-risk assessment
bentall procedure
benzphetamine
berlin heart excor
best trial (beta-blocker evaluation of survival)
best-cli trial
beta-2 agonists
beta-adrenergic blockade / beta-adrenergic blocker therapy
beta-blocker (b-blocker)
beta-blockers (non-vasodilating, cardioselective, av-nodal blockers)
beta-blockers / therapy / medications / optimal doses / uptitration
beta-blockers as adjunct to arb therapy
beta-blockers in aortic dissection
beta-blockers in pregnancy / postpartum
beta-carotene supplementation
beta-myosin heavy chain 7 (myh7)
bgn (biglycan, extracellular matrix protein)
bi-directional cavo-pulmonary shunt
bicarbonate
bicuspid aortic valve
bicuspid aortic valve (bav) / bav disease / bicuspid valve phenotype / bav-associated aneurysm / bicuspid vs tricuspid aortic valve outcomes / bicuspidoid aortic valve phenotyping
bicycle exercise testing
bidirectional cavopulmonary shunt (glenn shunt) / bidirectional shunt / shunting / anastomosis
bifid uvula
bifurcated grafting / bifurcation lesion / bifurcation lesion management
bilateral antegrade cerebral perfusion / bilateral cerebral perfusion
bilateral aortic injury (baai)
biliary excretion (liver metabolism of amiodarone)
binge drinking
bioavailability / pharmacokinetics / pharmacodynamics of diuretics
biochemical cardiac biomarkers
biochemical screening
bioimage study (personalized statin allocation)
bioimpedance
biologic disease-modifying antirheumatic drugs (dmards)
biologic prosthetic valve / biological prosthesis / biological valve / biological valved conduit
biologic-targeted therapy for takayasu arteritis
biologics / immune-modulating therapies
biomarker analysis / assay / domain / testing / utilization in acs
biomarker-guided therapy
biomarkers for af and stroke prediction
biomarkers for aortic risk stratification
biomarkers for heart failure (b-type natriuretic peptide, nt-probnp)
biomarkers for risk stratification in heart disease
biomarkers in asymptomatic aortic valve disease
biomarkers in hf therapy optimization
biomarkers of cardiac damage, injury, inflammation, strain
biomarkers: bnp, nt-probnp, troponin, high-sensitivity troponin, desmosine, proteomics, hs-crp
bioprosthesis / bioprosthetic valve / bioprosthetic prostheses
bioprosthetic aortic valve / mitral valve / pulmonary valves
bioprosthetic aortic valve durability / leaflet degeneration / stenosis / regurgitation / thrombosis / dysfunction / replacement / surgical or transcatheter
bioprosthetic tavi
bioprosthetic valve degeneration (leaflet calcification, non-coaptation, tear, perforation)
bioprosthetic valve replacement / bilateral bioprosthetic valve replacement
bioprosthetic valve thrombosis prevention (aspirin, warfarin, low-dose warfarin)
bioresorbable polymer-coated stent / bio-absorbable stent implantation
biosense webster (device manufacturer for cardiac rhythm management)
biotronik (device manufacturer)
biphasic cardioversion / energy (≥200 j) / waveform
birth prevalence of congenital heart defects
bisleaflet mechanical avr (aortic valve replacement)
bisoprolol
biventricular (bi-v) pacing / cardiac resynchronization therapy (crt) / biv pacing
biventricular circulation / dysfunction / function / global-function index / interaction
biventricular defibrillators (crt-d)
biventricular outflow tract reconstruction / repair / surgical strategy
biventricular vs right-ventricular pacing (block-hf)
blalock–taussig–thomas shunt
bleeding / anticoagulation-related bleeding / complications
bleeding academic research consortium (barc)
bleeding risk
bleeding risk assessment (scores: has-bled, hemorr2hages, atria)
bleeding risk factors / management / reduction / contraindications
bleeding risk in hf, acs, gi bleeding, intracranial bleeding
bleeding vs ischemic event risk
bleeding vs ischemic risk balance
blood cholesterol / dyslipidemia / management / lipid levels
blood clot / flow / distribution efficiency / volume / viscosity
blood culture / diagnostic standards / positivity / negativity / persistently positive
blood glucose / hba1c
blood pressure (bp) / hypertension / control / management / targets
blood pressure (bp) / hypertension / management / targets / measurement / control
blood transfusion / guidelines (aabb, cochrane review)
blood-flow metrics
blood-pressure-related vascular mortality
blowing (major/minor) bleeding
blue-toe syndrome
blunt abdominal aortic injury (baai)
blunt chest trauma
blunt thoracic aortic injury (btt-ai)
blunt traumatic abdominal aortic injury
blunt traumatic aortic injury (btai)
bmi as a risk factor (<21 kg/m² for thyrotoxicosis, bmi-adjusted hazard ratios for af)
bnp / b-type natriuretic peptide / brain natriuretic peptide
bnp level >300 pg/ml
body composition
body mass index
body mass index (bmi)
body size / habitus / perception / misperception
body size–indexed cardiovascular measurements
body surface area (bsa)
body surface area (bsa) indexed parameters
body temperature regulation
body weight
body-mass-index effects on transplant outcomes
body-size normalization of aortic dimensions / body-size–adjusted normal limits
boehringer ingelheim
bosentan (endothelin receptor antagonist) / therapy
bovine arch (common innominate and left carotid artery)
bowel ischemia (mesenteric ischemia)
bp control
bp control including intensive sbp <120 mm hg
bp lowering / bp-lowering therapy / bp-lowering treatment / drugs (β-blockers, ace inhibitors, calcium antagonists, diuretics)
bp lowering drugs / raas inhibitors / beta-blockers
bp management (general, hypertension, diabetes)
bp measurement (home, office, electronic)
bp reduction / trajectories / variation
bp response during exercise / homeostasis / cuff gradients / upper vs lower extremity
bp targets (<130/80 mm hg; 120–129/<80 mm hg; ≤130 mm hg systolic / ≤80 mm hg diastolic)
brady-tachycardia
bradyarrhythmia / bradyarrhythmias
bradycardia / bradycardia pacing / rate control
braf inhibitor (vemurafenib) / cardiotoxicity
brain abscess
brain arteriovenous malformation
brain infarction / brain stem infarctions
branch artery aneurysm
branch artery dilation or narrowing
branch artery occlusion
branch artery stenosis
branch endovascular therapy
branch pulmonary artery (pa) stenosis
branch pulmonary artery reintervention
branch pulmonary artery size and flow
branch stenting
branch vessel anatomy of the aorta
branch vessel aneurysm / aneurysmal disease
branch vessel ostia
branch vessel perfusion
branch vessel stenosis
branched endovascular aortic repair
branched graft
branched stent graft
breastfeeding-safe medications (acei, beta-blockers, diuretics)
bridge procedure
bridge therapy
bridge to cure
bridge to decision / bridge-to-decision strategy
bridge to recovery
bridge to surgery
bridge to transplant / bridge-to-transplant (btt) strategy
bridge trial
bridging / replacement anticoagulation strategies
bridging anticoagulation / bridging therapy
brisk physical activity
brockenbrough–braunwald–morrow sign
bromocriptine / bromocriptine therapy
brompton risk score
bronchial artery erosion
brugada syndrome
brugada syndrome / arrhythmogenic disorders
bruise-control trial
bruton tyrosine kinase inhibitors (btk inhibitors)
bsa indexing for aortic dimensions
bsa–adjusted z-score (general & lv wall thickness)
bucindolol
built environment
bumetanide
buprenorphine treatment
bupropion (treatment / nicotine replacement / nicotinic antagonist) / bupropion therapybreastfeeding in heart failure
buttock claudication
bypass / vascular bypass
bypass angioplasty revascularization investigation 2 diabetes (bari 2d)
bypass graft / conduit
bypass graft failure / occlusion
bypass graft patency
bypass graft surgery / cabg
bypass grafting (open or vascular surgery, including internal mammary arteries)
bypass grafts
bypass surgery / cabg
bypass time
bypass versus angioplasty (basil trial)
c-reactive protein as cardiovascular risk marker
c2hest score (coronary artery disease, hypertension, elderly, systolic hf, etc.)
cabg / coronary artery bypass grafting / cabg patch trials / study identifiers
cabg in cardiogenic shock
cabg indications and outcomes
cabg vs pci decision-making
cabg-associated complications
cad / coronary artery disease
caffeine consumption / abstention / triggers
cahp score (cardiac arrest hospital prognosis)
calcific aortic stenosis / calcific aortic valve disease
calcific mitral stenosis
calcific valve disease / calcific valvar stenosis / calcification of aortic wall or valves
calcineurin inhibitor therapy / elimination (e.g., cyclosporine, tacrolimus)
calcium channel blockers
calcium handling / ca²⁺ mishandling / overload / signaling / sensitization / supplementation
calibrated risk scores
canadian implantable defibrillator studies (cids)
cancer risk related to cardiac imaging or alcohol
cancer therapy–related cardiac disease
cancer-associated atrial fibrillation / cardiovascular risk
cancer-therapy–related cardiomyopathy / cardiotoxicity
car t-cell therapies (tisagenlecleucel, axicabtagene ciloleucel)
car-t cell therapy
carcinoid heart disease / carcinoid syndrome
cardiac amyloidosis
cardiac amyloidosis / al amyloidosis / ttr amyloidosis
cardiac amyloidosis / transthyretin amyloid cardiomyopathy
cardiac anticoagulation
cardiac arrest
cardiac arrest (documented, sudden, post-cpr, during transport)
cardiac arrest resuscitation guidelines
cardiac arrest studies (e.g., cash)
cardiac arrest study hamburg (cash trial)
cardiac arrhythmia suppression trial (cast)
cardiac arrhythmias / arrhythmia risk factors / arrhythmia suppression trial (cast / cats)
cardiac arrhythmias / rhythm control / re-entry circuits
cardiac bio-markers (general)
cardiac biomarkers
cardiac biomarkers of stretch, injury, or strain
cardiac biomarkers → nt-probnp, bnp
cardiac cachexia
cardiac care / critical care / icu outcomes / intensivist involvement
cardiac catheter ablation (including af with hf)
cardiac catheterization / catheter-based interventions / angiocardiography / coronary angiography
cardiac catheterization / catheter-based procedures / angiocardiography / coronary angiography
cardiac catheterization laboratory / interventional team / procedures / icu support
cardiac catheterization laboratory activation
cardiac chamber quantification
cardiac chamber quantification / size / function / guidelines
cardiac chamber size and geometry
cardiac chambers / chamber size / volume / structure / function
cardiac complications (myocardial injury, arrhythmias, ischemia, failure, death)
cardiac computed tomography (ct / cct / cta)
cardiac conduction / conduction system / conduction delay
cardiac conduits and grafts
cardiac contractility
cardiac contractility / contractility modulation (ccm)
cardiac contractility / performance metrics
cardiac device endocarditis
cardiac device implantation
cardiac device implantation / implantable electronic devices (cied)
cardiac device therapy
cardiac devices
cardiac dysfunction / heart failure / post-exercise cardiac dysfunction
cardiac electrophysiology / procedures / fellowship / ambulatory rhythm monitoring
cardiac embolization / thromboembolic disease (e.g., atrial thrombus, valvular vegetations, intracardiac shunts)
cardiac fibrosis
cardiac fibrosis / maladaptive structural changes
cardiac function / baseline assessment / monitoring / metrics (ef, stroke volume, systolic function)
cardiac hemodynamics (resting and exercise)
cardiac hypertrophy / chamber enlargement / pulmonary venous congestion
cardiac hypertrophy / remodeling / reverse remodeling / maladaptive structural changes
cardiac imaging (echocardiography, mri, ct, ct angiography, pet)
cardiac imaging for monitoring af burden
cardiac imaging guidelines / committees
cardiac imaging markers for cardiomyopathy
cardiac imaging modalities (invasive vs. non-invasive)
cardiac imaging parameters / metrics (e.g., lvesd, ef, wall thickness, lge)
cardiac index
cardiac intensive care unit (cicu)
cardiac interventions / myectomy / icd placement / surgical repairs
cardiac ischemia / acute or chronic ischemia
cardiac magnetic resonance (cmr / mri / perfusion imaging / lvot evaluation / myocardial mapping)
cardiac magnetic resonance imaging (cmr)
cardiac management strategies / decision-making
cardiac medication during pregnancy
cardiac monitoring (baseline, longitudinal, intermittent, continuous, echocardiography)
cardiac morphology / phenotypic spectrum
cardiac murmur
cardiac myosin (s2 region, alpha-myosin)
cardiac myosin inhibitors (e.g., mavacamten)
cardiac output / monitoring / augmentation / reserve / demands
cardiac pacemaker / atrial leads
cardiac pacing / physiological pacing / lv pacing / crt / conduction-system pacing
cardiac perfusion / myocardial oxygen delivery
cardiac pharmacokinetics (loading vs maintenance doses)
cardiac prevention / cardioprotective management strategies / cardioprotective exercise / cardioprotective effects (e.g., light-moderate alcohol)
cardiac procedural outcomes / surgical outcomes / operative risk
cardiac radiation exposure
cardiac rehab program / attendance / completion / access
cardiac rehabilitation
cardiac rehabilitation (cr) – center-based, home-based, virtual, exercise-based, cardio-oncology, post-mi/angina/scad, hfpef/hfmref, congenital heart disease, post-aortic surgery
cardiac repolarization abnormalities
cardiac resynchronization therapy (crt / crt-d / crt implantation / reverse remodeling)
cardiac resynchronization therapy (crt)
cardiac rhythm / rhythm abnormalities / rhythm disorder / rhythm monitoring / rhythm restoration / rhythm conversion time
cardiac rhythm management devices (pacemakers, defibrillators, crt devices)
cardiac risk assessment / risk index / risk score / risk stratification (including hcm, pregnancy)
cardiac safety / monitoring / safety assessment
cardiac sarcoidosis
cardiac shock / cardiogenic shock (classification, diagnostic criteria, management, protocols)
cardiac stress testing / stress imaging / stress laboratory
cardiac surgery (open-heart, cabg, valve replacement, repair, stenting, transcatheter intervention, post-operative arrhythmias, achd expertise)
cardiac surgical care / expertise / decision-making / education
cardiac sympathetic activity
cardiac symptoms / pulmonary-related cardiac symptoms (dyspnea, pulmonary edema)
cardiac tamponade
cardiac therapy adherence / cardiac therapies / cardiac toxicity
cardiac tissue destruction / infiltration / viral infiltrate
cardiac tolerance / long-term cardiac tolerance
cardiac transplant / transplantation (including bridge with mechanical assist device, muscular dystrophy, adult congenital heart disease, amyloidosis, valve regurgitation)
cardiac troponin
cardiac troponin (ctn, ctni, ctnt, assay, normalization)
cardiac ultrasound
cardiac valves / valvular pathology / valve disease / valve dysfunction / valve replacement / valve implantation / valve surgery
cardiac-related pharmacology / substance-specific cardiac effects
cardio-obstetrics
cardio-obstetrics care team
cardio-oncology
cardio-protective diet
cardio-renal considerations
cardiogenic limb emboli / cardioembolic events / cardioembolic stroke / cardioembolic risk / cardioembolic source
cardiogenic risk in primary prevention of cardiovascular disease
cardiogenic shock
cardiogenic shock / cardio-gic shock
cardiogenic shock revascularization strategy
cardioimmunology / cardiogenetics / inherited cardiac disease / genetic screening
cardiologist / achd cardiologist / aortic specialist / heart failure expert / maternal-fetal medicine specialist
cardiology / cardiology fellowship / guidelines / practice / editorial work / specialist roles
cardiometrics / cardiac performance / cardiac power output
cardiomyopathy
cardiomyopathy (dilated, idiopathic, ischemic, anthracycline-induced, trastuzumab-induced, peripartum, familial, af-induced, arrhythmia-induced, general, unresponsive)
cardiomyopathy genes / etiology / surveillance / program
cardiopulmonary bypass (including in pregnancy)
cardiopulmonary exercise testing (cpet)
cardiopulmonary exercise testing (cpet, treadmill, semi-supine bicycle, ventilatory efficiency, aerobic capacity, functional capacity, exercise tolerance)
cardiopulmonary magnetic resonance
cardiorenal syndrome
cardiorespiratory fitness
cardiorespiratory training
cardiorheumatology (cardiac involvement in systemic rheumatic disease)
cardioselective beta-blockers
cardiothoracic (ct)
cardiothoracic imaging / cardiovascular imaging / imaging modalities (tte, ct, mri, cmr)
cardiothoracic magnetic resonance imaging (cmr)
cardiothoracic surgeon / surgery / surgical specialties / surgical team
cardiothoracic surgery in hypertrophic cardiomyopathy
cardiotoxic anticancer therapies
cardiotoxicity / cardiotoxicity risk stratification
cardiovascular & metabolic sciences
cardiovascular & pulmonary rehabilitation
cardiovascular abnormalities / malformations / complications (e.g., turner’s syndrome, pregnancy, hiv, vasculitis, cancer therapy)
cardiovascular ageing
cardiovascular anesthesiologist / anesthesiologists
cardiovascular burden / morbidity / mortality / morbidity and mortality outcomes
cardiovascular catheterization / angiography / angioplasty / interventions
cardiovascular clinical trials
cardiovascular collapse
cardiovascular considerations (pregnancy, hiv, aortic care)
cardiovascular consultative services
cardiovascular device / implantable electronic device (cied) / device infection
cardiovascular disease
cardiovascular disease (cvd)
cardiovascular disease (cvd) / cardiovascular complications / risk / endpoints
cardiovascular disease epidemiology
cardiovascular disease prevention
cardiovascular disease prevention / primary & secondary prevention / preventive strategies / preventive guidelines (acc/aha, esc)
cardiovascular drug-drug interaction recommendations (e.g., statins)
cardiovascular drugs / pharmacotherapy / medication safety
cardiovascular effects (cocaine, ends, marijuana, opioids, second-hand smoke)
cardiovascular endpoints
cardiovascular event metrics / future ascvd events
cardiovascular events
cardiovascular events / event prevention / event reduction / event risk (mi, stroke, pad, arrhythmias, hf)
cardiovascular fellowship / fellowship program / interventional fellows
cardiovascular fitness / exercise capacity / rehabilitation (acvpr, aha, center-based, home-based, post-mi/scad/hf, cardio-oncology, pulmonary rehab)
cardiovascular functional class (nyha)
cardiovascular health / promotion / interventions / management / outcomes / equity / disparities / astronaut-specific outcomes
cardiovascular institute / research group / research institution / research network
cardiovascular magnetic resonance / cmr techniques / studies / imaging terms (dyssynchrony, remodeling, cone reconstruction)
cardiovascular mortality
cardiovascular operations / service line / services / status
cardiovascular or cv / cvd (general domain)
cardiovascular outcomes
cardiovascular outcomes / outcome metrics / outcomes research / trials
cardiovascular outcomes research / quality and outcomes research
cardiovascular phenotype / phenotyping
cardiovascular policy (e.g., smoke-free workplace)
cardiovascular procedures (general)
cardiovascular registry data
cardiovascular rehabilitation
cardiovascular research / research network / research programs
cardiovascular risk / risk assessment / risk prediction / risk profile / risk factor / risk reduction / risk management / risk stratification / risk amplifiers
cardiovascular risk classification
cardiovascular risk estimation
cardiovascular risk factors (bp, lipids, bmi, diabetes, smoking, alcohol, second-hand smoke, hyperlipidemia, dyslipidemia, comorbidities)
cardiovascular risk in smokers / e-cigarette users / pregnancy / autoimmune disorders
cardiovascular risk scores (framingham, cha₂ds₂-vasc, charge-af)
cardiovascular risk stratification
cardiovascular safety / safety assessment / toxicity
cardiovascular screening / screening guidelines
cardiovascular specialist / specialists / nurses / team-based care
cardiovascular stroke / cardio-embolic stroke
cardiovascular surgery indications
cardiovascular system / systems (including company names)
cardiovascular therapies (pharmacologic agents, device therapies)
cardiovascular-glycemic management (glp-1, sglt2 agents)
cardioversion (electrical, pharmacologic, direct-current, safety, energy delivery, la stunning)
cardioverter-defibrillator therapy
care coordination
care settings (inpatient / outpatient)
caregiver support
carotid artery disease
carotid atherosclerosis
carotid revascularization
carpal tunnel syndrome
carpentier–edwards pericardial bioprosthesis
carpreg ii risk score
carvedilol
cascade genetic testing
cascade screening of at-risk relatives
case management
case volume (center and surgeon)
cast-ii trial
castle-af trial
catecholamine spillover
catheter ablation
catheter ablation for atrial fibrillation
catheter ablation for ventricular arrhythmias
catheter-based cardiac interventions
catheter-based mechanical thrombectomy
catheter-based revascularization
catheter-based therapies
catheter-derived imaging
catheter-directed thrombolysis
catheter-related infection
causative factors of aortic aneurysm
cavopulmonary shunt
cavotricuspid isthmus ablation
cavotricuspid isthmus–dependent atrial flutter
ca²⁺/calmodulin-dependent protein kinase ii (camkii) activation / signaling / ryr2 hyperphosphorylation
cd4⁺ t cells
celecoxib
celiac artery
celiac artery coverage
cell and gene therapy
center for heart disease prevention
centerline measurement technique
centers for disease control and prevention (cdc)
centers for medicare & medicaid services (cms)
central adiposity
central aortic cannulation
central cannulation (aortic arch)
central nervous system event
central obesity
central sleep apnea
central venous access
central venous oxygen saturation
central venous pressure
cephalic vein
cephalosporins
cerebral abscess
cerebral amyloid angiopathy
cerebral aneurysm
cerebral embolism / thromboembolism
cerebral hemorrhage
cerebral infarction
cerebral ischemia
cerebral malperfusion
cerebral perfusion
cerebral protection strategies
cerebrospinal fluid drainage
cerebrospinal fluid pressure management
cerebrovascular complications
cerebrovascular disease
cerebrovascular events (stroke)
cervical artery abnormalities
cesarean delivery in cardiac or aortic disease
cesarean section
cessation counseling
chads₂ score
chamber dilation (ra, rv, lv)
chamber dilation / enlargement
chamber function
cha₂ds₂-vasc score
chelation therapy
chemotherapy-induced arrhythmias
chemotherapy-related cardiac monitoring
chemotherapy-related cardiotoxicity
chest pain
chest pain centers
chest pain evaluation
chest radiation therapy
chest radiography
chest tube output
chest x-ray
childhood / pediatric heart disease
childhood obesity
children’s heart foundation
cholesterol
cholesterol clinical practice guidelines
cholesterol management
cholesterol treatment trialists (ctt) collaboration
cholesterol-lowering therapy
chordal rupture
chordal-sparing mitral valve replacement
chromosomal abnormalities
chronic anticoagulation
chronic aortic dissection
chronic aortic regurgitation
chronic atrial fibrillation
chronic congestive heart failure
chronic coronary disease (ccd / cad)
chronic coronary disease (ccd)
chronic coronary syndrome (ccs)
chronic cyanosis
chronic disease management
chronic disease risk behaviors
chronic embolism risk
chronic heart failure
chronic hypertension
chronic hypoxemia
chronic inflammatory cardiomyopathy
chronic inflammatory disease
chronic kidney disease
chronic kidney disease (ckd)
chronic kidney disease stage 3–4
chronic limb-threatening ischemia (clti)
chronic lung disease
chronic management after scad
chronic mitral regurgitation
chronic myocardial infarction
chronic obstructive pulmonary disease (copd)
chronic obstructive pulmonary disease (copd) as cardiovascular comorbidity
chronic primary mitral regurgitation
chronic pulmonary regurgitation
chronic right ventricular pacing
chronic secondary mitral regurgitation
chronic severe aortic regurgitation
chronic stable angina
chronic stable ischemic heart disease
chronic symptomatic heart failure
chronic symptomatic peripheral artery disease
chronic tachycardia
chronic total occlusion (cto)
chronic type b aortic dissection
chronotropic incompetence
cibis trials (bisoprolol in heart failure)
cigarette smoking
cilostazol
cine cardiac imaging
cine ct imaging
circulating biomarkers
clarithromycin
clarity–timi 28 trial
class i antiarrhythmic drugs
class ia antiarrhythmics
class ib antiarrhythmics
class ic antiarrhythmics
class iii antiarrhythmic drugs
claudication
clear outcomes trial
cleft mitral valve
clevidipine
climate change–related cardiovascular risk
clingen (clinical genome resource)
clinical arrhythmias
clinical assessment
clinical atherosclerotic cardiovascular disease (ascvd)
clinical atrial fibrillation
clinical cardiac electrophysiology
clinical care pathways
clinical complications
clinical congestion
clinical consensus guidelines
clinical decision pathway (cdp)
clinical decision support for atrial fibrillation (cds-af tool)
clinical decompensation
clinical evaluation
clinical genetics
clinical heart failure assessment
clinical outcomes
clinical phenotyping of cardiomyopathy
clinical practice settings
clinical presentation
clinical registries and registry outcomes
clinical stability
clinical surveillance programs
clinical trials / randomized controlled trials
clinical utility of genetic testing
clinically actionable genetic variants
clinically evident atrial fibrillation
clonidine
clopidogrel therapy
closed mitral commissurotomy
clti management guidelines
cmr risk stratification
cmr tissue mapping
cmr-measured regurgitant fraction
coach trial
coact trial
coagulation cascade
coagulation monitoring (inr)
coagulopathy
coapt trial
coaptation length
coarctation of the aorta
cocaine use
cocaine-associated cardiomyopathy
coenzyme q10
cognitive disorders
cognitive impairment
colchicine therapy
colcot trial
collaborative / team-based cardiovascular care
collateral circulation
collateral vessel formation
color doppler imaging
color flow doppler
combined heart–liver transplantation
commander-hf trial
commissural calcification
commissural fusion
commit trial
common atrioventricular valve
community health workers
community-based cardiovascular care
community-based exercise therapy
compass trial
competing cardiovascular risks / outcomes
competitive sports participation in cardiovascular disease
complete atrioventricular septal defect (complete avsd)
complete heart block
complete revascularization
complex congenital heart disease
complex coronary / structural lesions
complex coronary artery disease
complicated aortic syndromes
composite bypass / valve–graft conduits
composite cardiovascular outcomes
composite clinical endpoints
comprehensive ascvd prevention
comprehensive atrial fibrillation care
comprehensive cardiac imaging
comprehensive cardiovascular care
compression stockings
computed tomographic angiography (cta)
computed tomography (ct)
computed tomography (ct) imaging
concentric left ventricular hypertrophy
concomitant cardiac conditions
conduction system disease
conduction system pacing
cone procedure for tricuspid valve repair
confirmatory diagnostic evaluation
congenital aortic valve disease
congenital cardiac anatomy variants
congenital cardiovascular abnormalities
congenital coarctation repair residual gradient
congenital coronary artery abnormalities
congenital heart disease
congenital heart disease (chd / achd)
congenital heart disease hemodynamics
congenital mitral valve disease
congenitally corrected transposition of the great arteries (cctga)
congestion and volume overload
congestive heart failure
congestive heart failure / heart failure
congestive hepatopathy
connective tissue disorders
connexins and cardiac gap junctions
conotruncal defects
conservative management strategies
constrictive pericarditis
consumer ecg devices
contained aortic rupture
contemporary cardiovascular management strategies
continuous anticoagulation therapy
continuous disease monitoring
continuous ecg monitoring
continuous intravenous inotropic therapy
continuous patient education
continuous positive airway pressure (cpap) therapy
continuous rhythm assessment
continuous rhythm monitoring
continuous st-segment monitoring
continuous-flow ventricular assist devices (lvads)
continuous-wave doppler
continuous-wave doppler ultrasound
contractile reserve
contraindications in cardiovascular therapy
contrast risk stratification (mehran score)
contrast-associated acute kidney injury
contrast-enhanced cardiovascular imaging
contrast-induced nephropathy (cin / ci-aki)
conventional cardiac pacing
conventional catheter ablation
conventional disease-modifying antirheumatic drugs (csdmards)
conventional treatment approaches
copy-number variants and de novo mutations
cor pulmonale
cor triatriatum
coronary angiography
coronary angiography (invasive and ct-based)
coronary artery anatomy
coronary artery anomalies
coronary artery bypass grafting (cabg)
coronary artery disease
coronary artery disease (cad / ischemic heart disease)
coronary artery disease (cad)
coronary artery stenosis >50%
coronary atherosclerosis
coronary atherosclerosis progression
coronary calcium scoring (cac)
coronary compression syndromes
coronary computed tomography angiography (ccta / cta)
coronary ct angiography (ccta)
coronary decision aids
coronary disease clinical outcomes
coronary dissection
coronary fistulas
coronary flow reserve (cfr)
coronary hemodynamics
coronary imaging
coronary imaging follow-up
coronary ischemia
coronary microvascular dysfunction
coronary physiology assessment (ffr / ct-ffr)
coronary plaque assessment
coronary plaque instability
coronary reintervention
coronary revascularization
coronary revascularization strategy selection
coronary risk factors
coronary risk modification
coronary risk scores
coronary risk stratification
coronary stent implantation
coronary thrombosis
coronary vasomotor disorders
corticosteroid therapy
cost and value considerations in cardiovascular care
cost estimation
cost of care
cost-effective medical management
cost-effective prevention strategies
cost-effective screening
cost-effectiveness
cost-effectiveness analysis
cost-effectiveness of aortic screening and intervention
cost-effectiveness of atrial fibrillation treatment
cost-effectiveness of cardiovascular devices
cost-effectiveness of cardiovascular therapies
cost-effectiveness of mechanical circulatory support
cost-related medication nonadherence
cost-saving healthcare strategies
cost-utility analysis
cost–value analysis of cardiovascular interventions
covered stents
covid-19 (coronavirus disease 2019)
covid-19 (sars-cov-2 infection)
covid-19 cardiovascular complications
covid-19 vaccination
covid-19 vaccination for cardiovascular risk reduction
covid-19–associated myocarditis
covid-19–associated thrombosis
covid-19–related myocardial injury
cox-2 selective inhibitors
crawford classification of thoracoabdominal aortic aneurysm
creatine kinase
creatine kinase-mb (ck-mb)
creatine kinase–mb
creatinine clearance
critical care atrial fibrillation
critical care cardiology
critical illness
critical limb ischemia
critical limb-threatening ischemia (clti)
critical time-to-treatment metrics
cross-clamp time
cross-clamp use
cross-sectional aortic area–to–height ratio
cross-sectional imaging
crossover rate in clinical trials
crt cost-effectiveness
crt with defibrillator (crt-d)
crt with pacemaker (crt-p)
cryoablation
cryoballoon ablation
cryptogenic stroke
ct angiography
ct aortic valve calcium scoring
ct grading of aortic injury
culprit lesion
culprit vessel
culprit-only percutaneous coronary intervention
cultural humility in healthcare
culture-negative endocarditis
cumulative radiation exposure
cumulative survival
current cardiovascular literature
current tobacco smoking
customized footwear for ischemia prevention
customized grafts
cyanosis
cyanosis-associated exercise limitation
cyanotic congenital heart disease
cyclooxygenase (cox) inhibitors
cyclophosphamide therapy
cyp-mediated drug metabolism
cyp2c19 polymorphisms
cystatin c
cytochrome p450 enzyme system
cytochrome p450–mediated interactions
cytokinetics
d-dimer
d-dimer threshold (<500 ng/ml)
d-sotalol
d-tga after arterial switch operation
d-tga after atrial switch (mustard/senning)
d-tga after rastelli operation
dabigatran therapy
danish trial (ischemic context excluded; scd comparator)
dapt duration
dapt duration after cabg
dapt risk stratification
de novo coronary lesions
de-escalation of dual antiplatelet therapy (dapt)
debranching (hybrid coronary/aortic context)
decongestion strategies
decopi trial
deep hypothermic circulatory arrest (surgical support technique)
deep vein thrombosis
deferred revascularization (ffr-guided strategy)
degenerative coronary disease
delayed coronary angiography
delayed hyperenhancement (myocardial infarction)
delayed invasive strategy in acs
delayed revascularization
delayed-enhancement cardiac magnetic resonance (ischemic scar imaging)
delta troponin change
demand-induced myocardial infarction (type 2 mi)
dense continuous-wave doppler signal (coronary hemodynamics context)
dental-related bacteremia (coronary risk in ie context)
depression
depression and heart failure outcomes
depression as a cardiovascular comorbidity
depression as a cardiovascular risk factor
depression as a risk amplifier
depression impacting heart failure prognosis
depression in cardiac populations (hf, achd, aortic disease)
depression, anxiety, and stress as cardiovascular risk factors
dermatologic toxicity
descending aorta
descending aortic aneurysm
descending aortic dilation
descending aortic replacement
descending thoracic aorta
descending thoracic aortic aneurysm
desmoplakin (dsp)
desmoplakin cardiomyopathy
desmoplakin gene variants / mutations
desmosomal gene mutations
destination therapy
destination therapy strategy
determinants of myocardial infarction onset
device bridging to transplant
device erosion
device extraction
device indications
device infection
device management (pacemakers, icds, crt)
device migration
device placement and selection
device surgery
device-based cardiac therapy
device-detected arrhythmia duration
device-detected atrial arrhythmias
device-detected atrial fibrillation
device-detected atrial high-rate episodes (ahre)
device-detected subclinical atrial fibrillation
device-related complications
device-related endocarditis
device-related thrombosis
device-related thrombus
dextro-transposition of the great arteries (d-tga)
diabetes as a cardiovascular risk factor
diabetes as a cardiovascular risk modifier
diabetes as a comorbidity in cardiovascular disease
diabetes care standards
diabetes in coronary artery disease
diabetes in heart failure
diabetes in peripheral artery disease (pad)
diabetes management
diabetes management as cardiovascular risk reduction
diabetes mellitus
diabetes-associated microvascular complications
diabetes-related ascvd risk
diabetes-related cardiovascular prevention
diabetes-related vascular disease
diabetic coronary artery disease
diabetic foot ulcer
diabetic neuropathy
diabetic retinopathy
diagnosis
diagnosis and management of atrial fibrillation
diagnosis and management of coronary artery disease
diagnosis and management of heart failure
diagnosis of chest pain
diagnosis of infective endocarditis
diagnosis of peripheral artery disease
diagnostic accuracy
diagnostic algorithms
diagnostic criteria
diagnostic evaluation
diagnostic imaging
diagnostic laboratory testing
diagnostic monitoring
diagnostic risk assessment models
diagnostic sensitivity and specificity
diagnostic testing (cardiovascular)
diagnostic thresholds
diagnostic workup for cryptogenic stroke
dialysis-dependent cardiovascular disease
diamond–forrester probability model
diastolic blood pressure
diastolic dysfunction
diastolic filling parameters
diastolic flow abnormalities
diastolic function
diet as a cardiovascular risk factor
diet quality
dietary fat intake
dietary fiber intake
dietary modification
dietary patterns
dietary patterns (e.g., mediterranean diet)
dietary potassium intake
dietary sodium intake
dietary sodium restriction
dietary supplementation
diffuse aortic dilation
diffuse atherosclerotic disease
diffuse coronary lesions
diffuse myocardial fibrosis
dig trial (digitalis investigation group)
digital care transformation
digital health
digital health interventions
digital health monitoring
digital health platforms and tools
digoxin (digitalis)
digoxin toxicity
dihydropyridine calcium channel blockers
dilated cardiomyopathy
dilated cardiomyopathy (dcm)
dilated-phase hypertrophic cardiomyopathy
diltiazem
dinamit trial
direct current cardioversion
direct oral anticoagulants (doacs)
direct thrombin inhibitors
direct-current ablation
discharge planning and education
discharge risk prediction models
discharge risk stratification
discrete coronary lesions
disease burden
disease management programs
disease progression
disease-modifying antirheumatic drugs (dmards)
disease-related morbidity and mortality
disopyramide
disparities in cardiovascular care and outcomes
dispersion of repolarization
disproportionate functional mitral regurgitation
dissecting aneurysm
distal aorta
distal aortic arch
distal aortic enlargement
distal aortic extension
distal ascending aorta
distal branch perfusion
distal convoluted tubule
distal embolization
distal flow reversal
distal pulmonary artery
distal subclavian artery
distention
distribution of aortic size
diuretic administration strategies (continuous vs bolus)
diuretic dose escalation
diuretic resistance
diuretic synergism
diuretic therapy
diuretic-refractory congestion
dizziness
doac pharmacokinetics and pharmacodynamics
dobutamine
dobutamine challenge
dobutamine stress echocardiography
docosahexaenoic acid (dha)
dofetilide
dominant vertebral artery
donor heart allocation
donor–recipient size matching
door-in–door-out time
door-to-balloon time
dopamine
doppler echocardiography
doppler hemodynamics
doppler ultrasound
doppler-based valve area
doppler-derived gradients
dormant conduction
dorsalis pedis pulse
dose adjustment
dose relationships
dose-adjusted anticoagulation
dose–response relationship
double outlet right ventricle
double valve replacement
double-chambered right ventricle (dcrv)
double-density sign of aortic dissection
double-orifice mitral valve
double-outlet right ventricle (dorv)
double-switch operation
down syndrome (trisomy 21)
downstream consequences of atrial fibrillation
doxazosin
dpp-4 inhibitors
dressler syndrome
dronedarone
drug classification
drug half-life
drug interactions
drug therapy
drug tolerability
drug-coated balloon angioplasty
drug-eluting stents
drug-eluting stents (des)
drug-induced arrhythmias
drug-induced heart failure
drug-induced lung toxicity
drug-induced torsades de pointes
drug-use–associated endocarditis
drug–drug interactions
dual antiplatelet therapy (aspirin + clopidogrel)
dual antiplatelet therapy (dapt)
dual antithrombotic therapy
dual antithrombotic therapy (dat)
dual therapy (oral anticoagulant + antiplatelet)
dual-chamber implantable cardioverter-defibrillator
dual-chamber pacing
dual-coil icd leads
dual-energy x-ray absorptiometry (dxa)
dual-organ transplantation
dual-site ventricular pacing
ductus arteriosus
duke criteria
duke treadmill score
dulaglutide
duplex ultrasound
duplex ultrasound surveillance
durability beyond 5–6 years
durability of repair or replacement
durable left ventricular assist device (lvad)
durable lvad or transplant pathways
durable mcs / destination therapy
durable mcs for lv or biventricular support
durable mechanical circulatory support (mcs)
durable prosthetic valves (tavi & surgical)
duration of atrial fibrillation / ahre
dynamic intraventricular obstruction
dynamic left ventricular (lv) obstruction
dynamic lv outflow tract (lvot) gradient / obstruction
dynamic lvoto detection and quantification
dynamic obstruction
dynamic resistance exercise
dynamic st-segment changes
dyskinesia
dyskinetic area
dyslipidemia
dyslipidemia management
dysmorphic features
dysphagia
dysphagia aortica
dysplastic pulmonary valve cusps
dyspnea / shortness of breath
dyspnea from tracheal compression or heart failure
dyspnea on exertion
e-cigarettes / e-cigarette use / electronic nicotine delivery systems (ends) / vascular remodeling
e/e′ ratio (diastolic function parameter)
early (<1 year) vs late (>1 year) aspirin initiation
early (<2 years) vs late (>2 years) statin initiation
early advance notification to pci-capable hospital
early age of disease onset
early aggressive invasive intervention for af (early-af)
early aldosterone blockade
early and late survival after valve replacement
early anticoagulation strategies (short-term, long-term)
early antihypertensive drug treatment
early aortic valve replacement
early change to oral antibiotic therapy for stable ie
early childhood (0–12 years) chd care
early childhood cognitive and sensory impairments (associated with phenocopies)
early clinical course
early corrective surgery
early death reduction
early detection of cardiomyopathy
early detection of subclinical myocardial injury
early developmental outcome in single-ventricle reconstruction
early discharge after pci / angioplasty
early discharge strategy
early eplerenone therapy
early follow-up (within 7 days of discharge)
early follow-up and lipid testing
early graft infection (≤3 months)
early initiation of oral beta-blocker therapy
early intervention / invasive strategy / surgical intervention
early invasive vs conservative strategy
early markers of myocardial dysfunction
early menopause
early onset sporadic tad
early post-discharge follow-up
early post-mi period
early postoperative atrial fibrillation
early postoperative complications
early predictors of poor outcome after cardiac arrest (e.g., neurological recovery)
early presenters (≤3 hours after symptom onset)
early repair strategy
early reperfusion / revascularization strategy
early repolarization pattern
early rhythm control / rhythm-control therapy in atrial fibrillation
early satiety
early surgery / surgical intervention (including severe aortic stenosis, nyha ii, post-mi)
early thrombosis / thrombotic events
early transfer to specialized center
early vhd
early vs delayed coronary angiography
early vs staged pci in cardiogenic shock
early-acs trial
early-age percutaneous balloon dilatation
early-onset stroke
early-stage hcm biomarkers
east-afnet 4 trial / study
ebstein anomaly
ebstein anomaly / ebstein’s anomaly
eccentric hypertrophy
ecg (electrocardiogram / 12-lead ecg)
ecg algorithm (r'' wave in v1 & terminal qrs vector in avf)
ecg changes (st-segment elevation, ischemia, infarction)
ecg conduction and repolarization abnormalities
ecg findings (pr-segment depression, concave st elevation, dynamic t-wave changes)
ecg interpretation / monitoring / follow-up
ecg interpretation criteria (st depression, st elevation, t-wave changes)
ecg lead placement for posterior ischemia
ecg monitoring / serial monitoring for nondiagnostic stemi
ecg qrs duration, fragmentation, voltage
ecg-gated acquisition
ecg-gated imaging / coronary ct angiography
echo-based assessment of valve function
echocardiographic assessment (2d, 3d, doppler)
echocardiographic assessment of obstruction severity / valve stenosis
echocardiographic diastolic parameters
echocardiographic doppler assessment
echocardiographic evaluation / features / imaging / indices
echocardiographic left atrial diameter
echocardiographic measures (velocity, pressure gradients)
echocardiographic predictors of outcome
echocardiographic quantification / quantitative assessment of valve disease
echocardiographic screening in first-degree relatives
echocardiographic sensitivity / specificity
echocardiographic strain imaging
echocardiography (2d, 3d, doppler, m-mode, strain imaging, tee, tte)
echocardiography (cardiac structure & function assessment)
echocardiography (screening modality, serial imaging, exercise echo)
echocardiography / echocardiogram (echo)
ecls-shock trial
ecmo-cs trial / randomized clinical trial
economic analysis of heart failure treatments
economic evaluation of pci vs medical therapy
economic stability / financial strain
economic value (intermediate, therapy, cost per qaly, icer)
economic value indicators: cost per qaly, icer
economic value of cardiomems / cardiovascular therapies
ectopia lentis (clinical sign of marfan)
edacs (emergency department assessment of chest pain score)
educational interventions / training for providers or patients
educational status
ef <50 % / ef ≤40 %
ef assessment / measurement / improvement / recovery
effective orifice area
effective refractory period (erp)
effective regurgitant area / orifice (ero / eroa, including ≥0.40 cm²)
egfr (estimated glomerular filtration rate)
egfr <15 ml/min/1.73 m²
eggs
ehlers-danlos syndrome (vascular type)
ejection fraction (ef / lvef / rv / lv)
elective aortic root replacement
elective ascending aortic replacement
elective cabg
elective non-cardiac surgery
elective repair / elective surgery
elective thoracic aortic repair
electrical cardioversion
electrical cardioversion / direct-current cardioversion
electrical dyssynchrony / fractionation / instability / remodeling
electrical posterior box isolation
electrocardiogram (ecg / ekg / 12-lead ecg)
electrocardiographic abnormalities (arrhythmias, av block, irregular r-r, absent p waves, fibrillatory waves)
electrocardiographic biomarkers
electrocardiographic left ventricular hypertrophy
electrocardiographic tracing interpretation
electrocardiography / electrocardiographic imaging of cardiac structures
electrocardiography implied by diagnostic context
electrode vector / electrode vector orientation (anterior-posterior, anterior-lateral)
electrogenic action of the sodium-calcium exchanger
electrogram frequency analysis
electrolyte abnormalities / balance / management
electrolyte monitoring (general, in af, in diuretic therapy)
electrolytes monitoring
electromechanical atrial function / dissociation
electronic cigarette effects / cardiovascular risk
electronic cigarettes / e-cigarettes / vaping / electronic nicotine delivery systems (ends)
electronic clinical decision support systems
electronic consults
electronic health record (ehr / emr / integration, cardiovascular assessment)
electronic health record (ehr)
electronic point-of-care reminders (for gdmt)
electrophysiologic / electrophysiological remodeling and structural remodeling of the atria
electrophysiologic determinants of conversion efficacy
electrophysiologic studies (eps) / programmed ventricular stimulation / inducibility testing
electrophysiologist
electrophysiology (ep) / electrophysiologic interventions / procedures / evaluation
electrophysiology ablation / endocardial ablation / catheter ablation
elevated ascvd risk / lifetime ascvd risk
elevated blood pressure / hypertension
elevated bnp / nt-probnp / natriuretic peptides
elevated cardiovascular biomarkers
elevated esr >50 mm/h
elevated filling pressures / right heart pressure
elevated glucose / transaminases / liver-function tests
elevated heart rate / jugular venous pressure (jvp)
elevated high-sensitivity crp (hs-crp)
elevated pre-therapy troponin ≥14 ng/l (>0.07 ng/ml)
elevated triglyceride levels
elevated white-blood-cell count
elevated-risk non-cardiac surgery
elite study (evaluation of losartan in the elderly)
emboli / embolism / embolization / embolic events (stroke, recurrent, systemic)
embolic risk / potential / prevention / of thrombi
embolic stroke of undetermined source
emerge trial
emergency action plans for sudden cardiac arrest in sport
emergency cardiovascular care / emergency surgery / emergency aortic repair / emergency coronary angiography
emergency department (ed) / ed management / triage / visits / length of stay
emergency medical services (ems) / transport / personnel (paramedics)
emergency revascularization / emergency invasive strategy (<2 hours from admission)
empa-preserved / empa-cardio / empa-reduced trial
empa-reg outcome trial
emperor-preserved / emperor-reduced study
end-diastolic pressure
end-of-life care
end-organ criteria (hepatic failure, renal failure, cardiac, low cardiac output, right/left ventricular dysfunction)
end-organ damage / dysfunction / hypoperfusion / ischemia / malperfusion / performance / perfusion
end-stage heart disease / heart failure / hypertrophic cardiomyopathy
end-stage kidney disease (eskd / dialysis dependence / extreme ckd stage linked to vascular disease)
end-stage renal disease (esrd / eskd)
end-stage renal function (egfr < 25 ml/min/1.73 m²)
end-systolic dimension (esd)
end-systolic volume index (esvi)
end-to-end anastomosis
endarterectomy (common femoral) / endarteritis
endo-tronic / endovascular therapy
endocardial ablation / biopsies / endomyocardial biopsy (emb)
endocardial imaging / involvement / leads / voltage mapping (evm) / healing / cushion tissue
endocarditis (diagnosis, classification, guidelines, prophylaxis, mortality, prosthetic valve risk)
endocrine / metabolic conditions (diabetes, obesity, acromegaly, pheochromocytoma)
endocrine therapy / endocrine toxicity (thyroid)
endograft (branched, fenestrated, endovascular repair, failure, migration, fracture, stenosis, sizing)
endografting / endovascular repair
endoleak (types i–v, early, late, proximal/distal, branch vessels, graft defects, endotension)
endoluminal aortic aneurysm repair / endoluminal revascularization
endothelial function / dysfunction / injury / disruption / endothelialization / tests
endothelin system / endothelin receptor antagonists / therapy (eras)
endovascular abdominal aortic aneurysm repair (evar / aaa repair)
endovascular aneurysm repair complications / follow-up / outcomes / vs open repair
endovascular aortic repair (including stent-graft, revar, thoracic stent-graft)
endovascular approach / techniques / technology / expertise / era outcomes / management
endovascular balloon occlusion (reboa)
endovascular devices (balloon angioplasty, drug-coated balloon angioplasty, atherectomy, stents)
endovascular femoropopliteal intervention
endovascular fenestration / stenting (first strategy)
endovascular infection / injury
endovascular limb revascularization / peripheral artery disease interventions
endovascular procedures / interventions / therapy
endovascular repair (evar / tevar / thoracic evar / thoracic aortic repair / stent grafting)
endovascular stent exclusion
endovascular stent graft / stent-grafting / stent-graft complications / delivery systems
endovascular therapy for pad, type b dissection, penetrating ulcers
endovascular thromboembolectomy
endovascular vs. open repair outcomes / surgical management
endowed chair in cardiology
endurance exercise
engage af–timi 48 trial
enoxaparin (low-molecular-weight heparin)
enrichd trial
environmental exposures / risk factors (air pollution, pm₂.₅, noise, heat waves)
environmental factors influencing cardiomyopathy
enzyme replacement therapy (e.g., agalsidase β)
enzyme-inducing antiseizure medications
epa/dha plasma levels
epicardial ablation / epicardial leads / icd system / pacemaker leads
epicardial coronary artery disease / spasm / obstruction / compression / fat / diameter reduction / apical site pacing / laa clipping
epicardial vessel / cad assessment
epidemiology / epidemiological studies (hf, hfref, hfpef, hcm, aneurysms, moderate-to-severe vhd)
eplerenone (emphasis-hf, ephesus trials)
epoprostenol therapy
eptifibatide
equity, disparities, and cost-effective long-term management / equitable care and training opportunities
ertugliflozin
esophageal compression / symptoms (dysphagia) / atrial fistula / lesion / varices
esp-cad trial
estimated 5-year sudden cardiac death risk
estimated glomerular filtration rate (egfr <60 ml/min/1.73 m² / <25 ml/min/1.73 m²)
estimated pulmonary pressures
estrogen-containing contraceptives / oral contraceptives (thromboembolic risk) / estrogen-only hormone regimens
ethnic disparities / ethnically and racially diverse populations
euclid trial (ticagrelor in pad / peripheral artery disease)
euthyroid state / euvolemia
event monitor / event recording (palpitations, light-headedness)
event-free survival
everest trial
everolimus-eluting stents
evidence
evidence gaps / future directions / research directions
evidence gaps in hf management
evidence grade / level of evidence (cor, loe, c-ld, b-nr, c-eo, etc.)
evidence review committee / evidence-based guideline implementation
evidence table / guideline recommendations
evidence-based care / guidelines / interventions / therapy / management / medicine / pharmacotherapy / methodology / methodologies / recommendations / terminology
evidence-based risk–benefit ratio (e.g., set in pad)
evm – endocardial voltage mapping
evolocumab (pcsk9 monoclonal antibody)
evopacs trial
ewolution trial
ex-dhf pilot study
exacerbation of hfref
examine trial (alogliptin outcomes)
excel trial
excessive alcohol intake
exenatide
exercise / physical activity (aerobic, resistance, modifiable risk factor, cardiovascular health)
exercise abi testing / treadmill abi
exercise adherence / compliance / counseling / rehabilitation / therapy / prescription / programs
exercise capacity / functional capacity / assessment / decline / improvement / preservation / metrics (vo₂ max) / testing / performance / exercise time / tolerance / pre-op / post-transplant / guidelines for chd athletes
exercise ecg / doppler echocardiography / echocardiography / stress echocardiography / treadmill / test / stress testing / tte / graded exercise test (gxt)
exercise hemodynamics / intensity (low, moderate, high, met values) / session duration / frequency / volume
exercise intolerance / limitation / restriction (including in desmosomal cardiomyopathy, fontan, myocarditis, hypertrophic cardiomyopathy)
exercise prescription parameters (treadmill walking, 6mwt)
exercise-based cardiac rehabilitation / telerehabilitation / cr programs / therapy for cvd, pad, aortic disease / supervised / home-based / structured / continuous / interval / resistance training / high-intensity aerobic / moderate-intensity / extreme exercise
exercise-induced cardiovascular events / ischemia / arrhythmia / lvot gradient / mitral regurgitation / angina / dyspnea / myocarditis / hypoxemia
exercise-induced desaturation
exercise-limiting cvd
exercise-related inflammation / acute cardiovascular events / exercise-induced lv pressure assessment
exertional angina / dyspnea / leg disorders / symptoms / performance / exercise capacity
expert consensus decision pathways for tobacco cessation
exposure to adversity (violence, trauma)
exposure to cardiotoxic agents
extended aortic repair
extended cardiac monitoring / ecg / external cardiac monitors
extended dapt / extended therapy beyond 1 year post-acs
extended septal myectomy (esm)
extended-release niacin
extensive lvot calcification
extent of late gadolinium enhancement (lge) on cmr / extensive lge ≥15% lv mass
extracardiac conduit / fontan conversion
extracellular matrix expansion / remodeling / proteins / extracellular volume / fraction
extracorporeal life support (ecls) / ecmo / ventricular assist devices
extract-timi 25 trial
extreme heat / temperature exposure
ezetimibe (npc1l1 inhibitor, add-on therapy, first strategy, ldl-c lowering)
fabry disease / fabry’s disease cardiomyopathy
factor xa / factor xa inhibitor / factor xa inhibitors (doacs: apixaban, rivaroxaban, edoxaban, enoxaparin)
factor xa inhibitors
failed reperfusion
failed surgical bioprosthetic valves
failing left ventricle / failing right ventricle
failure to rescue
fald (fontan-associated liver disease) / fenestration-associated liver disease
fall risk
false lumen / false lumen expansion / flow / hemorrhage / diameter >20–22 mm / thrombosis
fame study / fame-2 trial (fractional flow reserve vs angiography for multivessel evaluation)
familial aneurysm risk / familial thoracic aneurysm / familial thoracic aortic aneurysm (no identified gene) / familial thoracic aortic aneurysm and dissection (ftad) / familial thoracic aortic dilatation / familial thoracic aortic disease (tad) / familial thoracic aortic disease genetics
familial cardiomyopathy / familial cardiomyopathies
familial hypercholesterolemia (fh)
familial hypercholesterolemia (heterozygous)
familial inheritance (autosomal dominant pattern)
fast-mi program
fatigue
faust trial (femoral arterial access with ultrasound)
fda adverse event reporting in anticoagulation therapy
fdg-pet / fdg-pet/ct / fluorodeoxyglucose positron emission tomography / fluorodeoxyglucose–positron emission tomography
felodipine
female sex / female predominance / sex-specific differences / female under-diagnosis of hcm / female-sex cardiovascular risk
femoral access / femoral artery access / femoral cannulation / femoral endarterectomy / femoral pulse / femoral pulse delay / femoral vascular access
femoropopliteal arterial disease / segment / bypass / lesions / angioplasty / disease
fenestrated aortic repair / fenestrated closure / fenestrated endovascular aortic repair / fenestrated endovascular device / fenestrated stent graft / fenestrated surgical repair / fenestrated transcatheter device / fenestrated/branched endovascular procedures (fevar/bevar) / fenestrated/endovascular aneurysm repair (fevar/evar) / fenestrated/obstructive membrane orifice / fenestrated-branched endograft / fenestrated-branched endovascular aortic repair (fevar)
fenofibrate
fentanyl
ferric carboxymaltose (iron therapy in hf with iron deficiency)
fertility / family planning in achd patients
fetal complications / counseling / death / echocardiography / growth effects / growth retardation / intracranial bleeding / malformations / monitoring / outcome / screening
ffr – fractional flow reserve / ffr-derived from ct angiography (ffr-ct) / ffr-guided pci / ffr-guided pci (≤0.8)
fibrates
fibrin / fibrinogen / fibrinolysis / fibrinolytic therapy / fibrinolytic agents / fibrin-specific fibrinolytic agents / fibrinolytics
fick cardiac output / fick method
filling pressure / filling pressures (e.g., left-systolic filling pressure)
financial strain
fincv study
fint-stemi trial
fish oil / supplementation
fixed radiographic imaging system and flat-panel fluoroscopy / fluoroscopy
flail leaflet / flail tricuspid leaflet
flecainide / flecainide (antiarrhythmic) / flexenide / flec-sl trial (short- vs long-term antiarrhythmic)
flow assessment / flow quantification / flow diagrams / flow diagrams for cardiac decision pathways
fluid administration / balance / management / input-output monitoring / restriction / removal rate / resuscitation / overload / retention / shifts / status / fluid-retention risk factors in diabetes treatment
fluvacs study (flu vaccination in acute coronary syndromes)
fluvastatin (40–80 mg, oral, xl, bid)
focal aortic aneurysm / pseudoaneurysm / dissection / focal atherosclerotic lesions / focal atrial tachycardias / focal impulse modulation / focal intimal disruption / focused intimal disruption (fid)
follow-up after discharge
follow-up and monitoring
follow-up and monitoring of bicuspid aortic valve
follow-up aneurysm-related mortality
follow-up appointments
follow-up arrhythmia monitoring
follow-up assessment
follow-up echocardiography
follow-up exercise testing restriction
follow-up imaging in myocarditis
follow-up imaging intervals (1 month, 6 months, 12 months, annually, every 5 years)
follow-up interval recommendations (e.g., 3‑month cmr, 196‑day imaging)
follow-up intervals (physiological stages a–d, asymptomatic severe/moderate as, isolated branch pulmonary artery stenosis)
follow-up intervals / outpatient, ecg, tte
follow-up studies / treatment outcomes
fondaparinux
fontan circulation / fontan surgery / univentricular physiology
fontan circulatory failure / fontan failure / obstruction / pathway stenosis
fontan completion / procedure / revision / conversion / total cavopulmonary fontan
fontan conduit stent-angioplasty / pathway conduit (extracardiac conduit)
fontan palliation / fontan physiology / fontan patient / fontan pressure / fontan outcomes network
fontan-adult brompton clinical score
fontan-associated complications / thrombosis / thrombus / liver disease (fald) / portal hypertension / transplantation indications / screening
fontan-associated liver disease
food access / food security / food effect (high-fat, high-calorie meal)
food access / food security / nutrition considerations
food insecurity / screeners
forced expiratory volume in 1 second (fev1)
forward cardiac output / forward stroke volume
four-dimensional ct imaging (4d ct) / 4d flow mri
four-factor prothrombin complex concentrate (pcc)
fourier study / trial (pcsk9 inhibition in high-risk patients)
fourier study – cardiovascular outcomes research
fourth heart sound
fourth primitive dorsal aortic arch
fractional area change
fractional flow reserve (ffr) / ffr vs angiography / ffr-guided pci / trials: fame, fame-2, frame-ami, famous-nstemi
fractional shortening
fragmented qrs complex
frailty / frailty assessment / frailty indices / frailty score
frailty as risk factor for poor self-care / impacting survival <1 year / predictor of outcomes in cad / immobility / fragile tissue integrity / sarcopenia (muscle loss)
frailty in achd / chronic heart failure
free wall rupture
freedom from recurrent moderate/severe mr / freedom from reoperation
freedom study / trial
fresh frozen plasma (ffp) / in over-anticoagulation
fried foods
friedewald equation (ldl-c estimation)
frozen elephant trunk (fet) / procedure / repair / technique
functional assessment / structural cardiac assessment / functional and anatomic testing modalities
functional assessment in elderly mi patients with multivessel disease (fire trial)
functional capacity (exercise capacity, age- and sex-adjusted, peak vo₂, dyspnea on exertion, improvement, assessment)
functional capacity assessment
functional class (nyha/who, assessment, improvement post-pulmonary valve replacement)
functional coronary assessment / functional ischemic mitral regurgitation / functional tricuspid regurgitation (secondary to chronic af) / functional stenosis / functional vs structural valve causes
functional domain / functional impairment / functional decline / functional exercise capacity
functional indices (e.g., nyha class)
functional limitation / functional limitation grading / of claudication / provocable lvoto, abnormal bp response, arrhythmias, etc.
functional mitral regurgitation
functional outcome / functional outcomes / functional status (decreased, exercise tolerance, hf, mobility limitations, walking performance metrics) / functional status and limitation / functional status decline in pad / functional status improvement / functional status measures in elderly cardiac patients
fungal aortitis / fungal endocarditis / fungal prosthetic valve endocarditis / fungal infection
furosemide / oral loop diuretic
fusiform aneurysm
future baffle occlusion
future directions in pad treatment
future research directions (hf)
future research needs (ccd)
g-protein–coupled receptor blockers (arni)
gadolinium enhancement (cardiac mri)
gadolinium-based contrast agents / media
galectin-3
galileo trial / gauss-3 trial / gissi-hf trial / gissi-prevenzione trial / global leaders trial / get with the guidelines (gwtg) registry / gwtg-hf registry / goals study
gangrene / gluteal ischemia
garfield-af risk score / score
gastric / intestinal absorption of p2y12 inhibitors
gastric bypass surgery
gastrointestinal bleeding / gastric bleeding / intestinal bleeding
gastrointestinal malignancy
gated cardiac ct
gcm – giant cell myocarditis / giant-cell myocarditis / giant cell aortitis / giant cell arteritis (gca)
gdf-15 (growth differentiation factor-15)
gender / sex / gender differences / gender disparities / gender-identity disparities
gender differences in aortic aneurysm growth and outcomes / rupture risk / imaging limits
gender-affirming therapies (impact on arrhythmia, achd)
gender-specific risk models
gene carriers (hcm genetics) / gene variant carriers
gene expression profiling / gene-expression profiling (cardiac)
gene therapy (cardiac) / gene-based therapy / gene-specific therapeutics / gene-based management
general anesthesia / general or epidural anesthesia (peri-operative risk / during delivery)
general cardiologists / geographic availability of achd cardiologists
genetic and pathobiological causes of valve dysfunction
genetic aortopathy / genetic aortic disorder / genetic aortopathies
genetic associations / genetic determinants / genetic factors / gene-by-environment interaction
genetic compound or double mutations
genetic counseling (pre-pregnancy / preconception / for inherited aortopathies / for myocarditis / for congenital heart disease / cascade screening)
genetic dilated cardiomyopathy
genetic evaluation / referral / genetic evaluation for high-risk phenotypes / cardiomyopathy / thoracic aortic disease
genetic predisposition / risk / penetrance / susceptibility / triggers
genetic sarcomere variants / mutations (lox, smad6, acta2, mylk, myh11, prkg1, mly2, titin, lamin a/c, ttr, other hcm or aneurysm-related genes)
genetic testing (cardiogenetics / multigene panel / exome sequencing / syndromic features / family history / hcm-associated variants / ttr mutation / inherited cardiovascular disease / thoracic aortic disease / cardiomyopathy / arrhythmia genes / ion-channel disorders)
genetic testing outcomes / genetic variant re-analysis / re-contact guidelines
genetically inherited heart diseases / genetics / heritability / genetics-mediated risk stratification
genital / genitourinary infections / mycotic infection
genomic/locus identification for af / gwas for af / polygenic risk score / genetic susceptibility loci
genotype / genotype-positive / genotype-negative / genotype-phenotype correlation / genotype-positive screening of family members / genotype-based risk stratification
geographic disparities (urban vs rural, clinician shortages, isolation)
geriatric 5ms (mentation, mobility, medications, multicomplexity, what matters)
geriatric depression scale (gds ≥ 6)
geriatric nutritional risk index (gnri)
geriatric syndromes (frailty, mobility impairment, multicomplexity, depression, nutrition risk, etc.)
global and regional myocardial blood flow
global burden of disease (gbd) cardiovascular studies / references / data on coronary disease
global longitudinal strain (gls)
global use of strategies to open coronary arteries (gusto) / gusto classification
global vascular guidelines on chronic limb-threatening ischemia
glomerular filtration rate (gfr) / glomerulonephritis
glp-1 receptor agonists
glp-1 receptor agonists / glucagon-like peptide-1 receptor agonists (e.g., liraglutide, semaglutide, exenatide, lixisenatide, tirzepatide) / glp-1 ra cardiovascular outcome agents
glucose control / glycemic control / hba1c targets / abnormal glucose / diabetes management
glucose-lowering medical therapy (gdmt / guideline-directed therapy / glucose-directed therapy / glycemic-controlled disease management)
glycated hemoglobin (hba1c)
glycemic treatment strategies / guidelines / agents affecting hf risk (metformin, insulin, sulfonylureas)
goals of care (symptom relief, qol, life prolongation)
gorlin equation / formula (mitral area calculation)
gout / gout and gallstones (e.g., bempedoic acid adverse effect)
grace risk score / grace >140
graft failure / graft dysfunction / graft defect / graft misalignment / graft migration / graft porosity / graft infection / graft-related complications / graft enteric erosion / graft explant / graft revision / graft site inflammation
graft patency (primary, assisted primary, secondary) / graft thrombectomy / graft surveillance
graft type comparison (prosthetic vs autogenous)
green tea extract (observational therapy)
group-oriented arterial leg study (goals)
growth rate of aneurysm / aaa / aortic aneurysms (mm/year, ≥0.3–0.5 cm/year)
guide-hf trial / study
guide-it (guiding evidence-based therapy using biomarker-intensified treatment) / predictive model
gusto trial / gusto-i trial (global utilization of streptokinase and tpa) / gusto moderate or severe bleeding
gwtg-hf (get with the guidelines – heart failure) registry / risk score
h/cl ratio (heart-to-contralateral chest ratio)
h2fpef score
hacek organisms
halo catheter
handheld ecg device
harmonize trial (sodium zirconium cyclosilicate)
has-bled bleeding risk score
hatch score
hazard ratio
hazard–benefit ratio
hba1c variability
hcm clinical guidelines
hcm risk prediction models
hcm specialty / comprehensive centers
hcm with atrial fibrillation
hcm with ventricular arrhythmias
hdl cholesterol
heaal study
headache
health abc heart failure score
health behaviors
health coaching
health disparities / health inequities
health education
health equity initiatives
health information technology
health literacy
health numeracy
health policy and quality metrics
health services research
health-related quality of life (hrqol)
health-status outcomes
healthcare access
healthcare cost
healthcare cost burden
healthcare disparities
healthcare resource utilization
healthcare utilization
healthy diet
healthy diet / dietary patterns
healthy lifestyle behaviors
heart allocation policy
heart arrest
heart attack (myocardial infarction)
heart block / conduction disorders
heart disease
heart disease imaging
heart disease management
heart disease pathophysiology
heart disease prevention
heart disease prognosis
heart disease risk factors
heart disease statistics
heart failure
heart failure (hf)
heart failure action study
heart failure associated with atrial fibrillation
heart failure biomarkers
heart failure diagnosis
heart failure disease staging
heart failure health disparities
heart failure hospitalization
heart failure in diabetes mellitus
heart failure in older adults
heart failure in pregnancy
heart failure in racial and ethnic minority populations
heart failure in women
heart failure morbidity and mortality
heart failure mortality
heart failure outcomes
heart failure pharmacologic therapy
heart failure prevention
heart failure prognostic markers
heart failure progression
heart failure readmission
heart failure related to congenital heart disease
heart failure remission
heart failure secondary to myocardial infarction
heart failure stages (a–d)
heart failure survival
heart failure survival score
heart failure symptoms
heart failure with improved / recovered ejection fraction
heart failure with mildly reduced ejection fraction (hfmref)
heart failure with preserved ejection fraction (hfpef)
heart failure with reduced ejection fraction
heart failure with reduced ejection fraction (hfref)
heart murmur
heart protection study (hps)
heart rate
heart rate control
heart rate management
heart rate recovery
heart rate reserve
heart rate variability (hrv)
heart rhythm
heart rhythm assessment
heart rhythm management
heart transplant allocation policy
heart transplant candidacy
heart transplant evaluation
heart transplant listing
heart transplant outcomes
heart transplant rejection
heart transplantation
heart valve
heart valve centers of excellence
heart valve disease
heart valve dysfunction
heart valve programs
heart valve prosthesis
heart valve repair
heart valve replacement
heart valve surgery
heart-healthy diet
heart-healthy lifestyle behaviors
heart-related morbidity and mortality
heart-related quality of life (hrqol)
heartflow (ffr-ct platform)
heartmate 3
heartware hvad
heart–kidney transplantation
heart–liver transplantation
heart–lung transplantation
heat exposure
heat-related hospitalization
height
helical computed tomography
hematocrit
hematologic abnormalities
hematology-guided antithrombotic management
hematoma
hemochromatosis
hemochromatosis-related heart failure
hemodialysis
hemodynamic assessment
hemodynamic compromise
hemodynamic decompensation
hemodynamic durability
hemodynamic instability
hemodynamic monitoring
hemodynamic outcomes
hemodynamic overload
hemodynamic progression
hemodynamic response
hemodynamic severity
hemodynamic significance
hemodynamic stress
hemodynamic success
hemodynamically significant coarctation
hemodynamically significant lesion
hemodynamically stable patient
hemodynamically unstable patient
hemodynamics
hemoglobin
hemoglobin a1c
hemolysis
hemolytic anemia
hemopericardium
hemoptysis
hemorrhage
hemorrhagic shock
hemorrhagic stroke
hemostasis
hemothorax
heparin
heparin infusion
heparin-induced thrombocytopenia (hit)
hepatic dysfunction
hepatic fibrosis / cirrhosis
hepatocellular carcinoma
hepatorenal syndrome
hepatotoxicity
heritable bicuspid aortic valve
heritable thoracic aortic aneurysm
heritable thoracic aortic disease (htad)
heterotaxy syndrome
hfa-peff diagnostic algorithm
high cardiovascular risk
high risk ascvd
high risk cardiovascular profile
high risk drinking
high-sensitivity cardiac troponin dynamics
history of stroke
history of transient ischemic attack
hiv infection
hope trial / hope-3 trial
hypercholesterolemia
hyperlipidemia
hyperlipidemia / high cholesterol / triglycerides / ldl-c / hdl-c
hypertension
hypertriglyceridemia
hypertrophic cardiomyopathy
hypertrophic cardiomyopathy (hcm)
hypotension
ibrutinib and other anticancer therapies with cardiac toxicity
implantable and wearable cardiac monitors
incremental cost-effectiveness ratio (icer)
infective endocarditis
infective endocarditis with coronary complications
intracardiac abscess
intracardiac or paravalvular abscess
intracardiac shunt
intracardiac thrombus
ischemia with nonobstructive coronary arteries
ischemic cardiomyopathy
ischemic heart disease
ischemic heart failure
ischemic mitral regurgitation
ischemic risk stratification
ischemic stroke
lead-related tricuspid valve dysfunction
left ventricular hypertrophy
left ventricular noncompaction
left ventricular outflow tract obstruction
loop diuretics
low-flow low-gradient aortic stenosis
low-gradient aortic stenosis
low-molecular-weight heparin
low-weight vs high-weight
lyme carditis
lysosomal storage disease
major adverse cardiovascular events (mace)
major adverse coronary events
major, moderate, minor, life-threatening
management of multivessel cad in stemi
maze procedure
mechanical circulatory support devices
mechanical complications
mechanical complications of mi
metabolic syndrome
mitral commissurotomy
mitral regurgitation
mitral stenosis
mitral valve disease
mitral valve prolapse
mortality and morbidity outcomes
multi-organ transplantation
multimodality aortic imaging
multivessel vs culprit-only revascularization
myocardial infarction
myocardial ischemia
myocarditis
myocarditis (complicated)
neurocognitive dysfunction
nondihydropyridine calcium channel blockers
nonsteroidal anti-inflammatory drugs (e.g., diclofenac)
non–vitamin k oral anticoagulants
nt-probnp appears in previous batches under biomarkers
nutrition counseling / dietitian involvement
nyha functional class ii–iv
obesity
obstructive sleep apnea
older adults
older age
opioid use
overweight
p-glycoprotein interactions
p2y12 inhibitor de-escalation strategies
paroxysmal dyspnea
patent ductus arteriosus
patent foramen ovale
pediatric risk models (hcm risk-kids)
percutaneous coronary intervention (pci)
perfusion reserve
pericarditis
peripheral arterial disease
peripheral artery disease
peripheral artery disease (pad)
permanent cardiac devices
pharmacogenomics in cardiovascular therapy
pharmacologic diabetes management
physical activity
poor glycemic control as a modifiable cardiovascular risk factor
portable / hand-carried echocardiography
post-infarction ventricular septal rupture (vsr)
post-procedural complications
post–myocardial infarction management
pregnancy and conception in aortic disease
prothrombotic states associated with chemotherapy
pulmonary arterial hypertension
pulmonary artery dilation
pulmonary artery intervention complications
pulmonary artery stenosis
pulmonary atresia
pulmonary embolism
pulmonary hypertension
pulmonary regurgitation
pulmonary stenosis
pulmonary valve disease
pulmonary valve regurgitation
pulmonary valve stenosis
pulmonary vein isolation
quality of life outcomes
quality-adjusted life years (qalys)
quality-of-life assessment instruments (e.g., sf-36)
radial artery, ulnar artery, distal radial artery
reentrant atrial flutter circuits
renal failure
renal function–guided drug dosing
reproductive planning and contraception in cardiovascular disease
resting heart rate
restrictive cardiomyopathy
revascularization in acs with cardiogenic shock
rheumatic heart disease
right ventricular dilation
right ventricular dysfunction
right ventricular failure
right ventricular hypertension
right ventricular hypertrophy
right ventricular outflow tract obstruction
right-to-left shunt
right-to-left shunting
risk discrimination metrics (c-index)
risk reduction strategies
secondary prevention of coronary disease
septal defects (asd/vsd)
serum creatinine
sex (gender)
sglt2 inhibitors
shared decision-making in coronary revascularization
sick sinus syndrome
smoking
social and environmental cardiovascular risk factors
specialized cardiovascular centers
stable angina
statin therapy for primary prevention
statistical confidence intervals
stroke
stroke risk (hcm-risk-cva)
stroke risk stratification in atrial fibrillation
subaortic stenosis
substance use
sudden cardiac arrest
sudden cardiac death (ischemic etiology)
sudden cardiac death risk (hcm-risk-scd)
supplemental oxygen therapy in acute mi (deto2x-ami trial)
supravalvar aortic stenosis
supraventricular tachycardia
systemic embolism
systemic right ventricular failure
systolic bp (sbp) and diastolic bp (dbp)
t-cell exhaustion marker (cd69)
target heart rate
tetralogy of fallot
thoracic aortic aneurysm
thoracic aortopathy genetic variants
thresholds (<60 kg)
thromboembolism
thrombosis
timing of intervention in acute coronary syndromes
tobacco use
transient ischemic attack
transplant hepatology
transposition of the great arteries
transthyretin amyloidosis disease-modifying therapies
travel distance to care
tricuspid regurgitation
tricuspid stenosis
tricuspid valve disease
truncus arteriosus
ttr disruptors
ttr silencers
ttr stabilizers
type 1 diabetes mellitus
type 2 diabetes mellitus (t2dm)
ultrafiltration / aquapheresis
unfractionated heparin
unhealthy diet
unsaturated fatty acids
unstable angina
value assessment in cardiovascular guidelines
vascular risk factor
ventricular fibrillation
ventricular septal defect
ventricular tachycardia
visceral adiposity
visceral artery involvement in aortic aneurysm (celiac, sma, renal)
waist circumference
waist-hip ratio
warfarin
weight assessment
weight loss
weight management
whole-grain diet
